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ABSTRACT 
 
 
Background 
 
 Typhoid  fever is a prevalent disease among paediatric population, 
and it leads to a diagnostic dilemma whenever a child presents with acute 
febrile illness.  Rapid, simple and reliable diagnostic tests for typhoid fever 
is a long felt need for pediatricians.   The typhidot assay is a recently 
available rapid serological diagnostic test for the diagnosis of typhoid fever. 
 
Aim and Objectives 
 This study was conducted to find the reliability of typhidot assay over 
widal test in comparison to gold standard blood culture method, and also to 
find antibiotic sensitivity pattern of causative organism, clinical features of 
typhoid fever. 
 
Material and Methods 
 A total of 167 children with clinical suspicion of typhoid fever 
enrolled in the study and a detailed clinical examination, routine laboratory 
investigation for fever workup and typhidot assay, widal test and sample for 
blood culture taken.  Patients were observed for clinical outcome and 
laboratory features. 
 
Observations 
 26 children had positive blood culture.  The sensitivity, specificity, 
positive predictive value and negative predictive value of the typhidot assay 
88.46%, 81.56%, 46.94% and 97.46% respectively.  The typhidot assay was 
found to be more reliable than widal test to diagnose typhoid fever. 
 
Conclusion 
 The typhidot assay can be used as a suitable alternative to widal test in 
regions were facilities for culturing the blood is not available to diagnose the 
typhoid fever.  The 3rd generation cephalosporin Ceftriaxone is suitable for 
empirical first line theraphy than Ciprofloxacin as there is a increasing trend 
in NARST.  
 
 Key words : typhoid fever, typhidot assay, widal test, sensitivity.  
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INTRODUCTION 
  Enteric fever is a potentially fatal multisystemic disease due to the 
causative organism Salmonella enterica serovar typhi (S.Typhi). A related 
but milder disease is caused by S.Paratyphi A and less frequently by S. 
Paratyphi B and S. Paratyphi C. The term enteric fever comprises both 
typhoid and paratyphoid fever1. Enteric fever remains as a main public 
health problem of the paediatric age group in developing countries and 
cause significant morbidity and mortality in spite of tremendous advances 
in the fields of pharmacology, microbiology and preventive medicine. 
The extensive distribution of the organism in the ecology, its 
emergent prevalence in the global food chain, virulence and adapting 
capabilities results in enormous economical, medical, public health 
impact worldwide. 
Without delay in treatment and proper antibiotic drugs, typhoid 
fever is usually a short term febrile illness. Treated it has few enduring 
consequences and a 0.2% death rate. If left untreated it is a life 
threatening disease of many weeks duration with long term morbidities. 
Increasing prevalence of antibacterial resistance and need for 
hospitalization are other problems associated with enteric fever.  
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ORGANISM 
S.Typhi is a highly human specific organism. It evolved 15000 to 
50000 years ago and has highly adapted remarkable mechanisms for 
persistence in its human host37. It has no other natural host. S. typhi share 
many genes with Escherichia coli and at least 95% with S. typhimurium, 
many typical clusters of gene called as “pathogenicity islands” and 
related genetic materials have been obtained in the process of evolution. 
The paucity of single genes, gaining or loss of single genes or large 
islands of DNA fragments led to adaptation and restriction S. typhi to 
humans1. 
 
(Salmonella typhi growing over gall stones) 
  The name salmonella appeared after the pathologist D.E. salmon, 
who first isolated the S. Cholerasuis from pork intestine. The genus 
salmonella is classified into two species, each with multiple subspecies 
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and serotypes. The two species of salmonella is a genus of family 
Enterobacteriaceae. The two species of salmonella were salmonella 
enterica and salmonella bongori. The difference between two is SPI-2 
(salmonella pathogenicity island) that is absent in S.bongori serotypes. 
As per current salmonella nomenclature system in use at U.S. 
centres for Disease control and prevention and W.H.O. laboratories the 
full taxonomic designation Salmonella enterica subspecies enterica 
serotype Typhi can be minimized to Salmonella serotype Typhi or 
Salmonella Typhi3. 
Depending upon the recognition of formula for structures of O and 
H antigens by agglutinating techniques Salmonella are classified in 
kauffman-white scheme. A total of 2555 serovars defined in this system. 
Since L. Le minor explained most of the known serovars this is 
redesignated as White-Kauffman- Le minor scheme. 
EPIDEMIOLOGY 
Typhoid fever occurs all over the world, mostly in developing 
countries where environmental sanitation is poor. Endemicity is observed 
in Asia , Africa , Latin America , the Caribbean and Oceania , but 80% of 
total typhoid fever cases were from Bangladesh, china, India , Indonesia , 
Laos , Nepal, Pakistan and Vietnam4. Typhoid fever infects 
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approximately 21.6 million people (incidence of 3.6 /thousand 
populations) and kills approximately 200,000 people annually. Incidence 
varies in developing countries, ranging from 100 to 1000 /100,000 
population. 
(World map showing prevalence of typhoid fever. India comes under 
high prevalence region.)  
   The public health burden of typhoid fever in India is massive. 
Population based study done in New Delhi estimated the incidence of 
typhoid fever as 2730 per 1 lakh population in the age group of 0-4 years, 
1170 per 1 lakh in the age group in 5-19 years , 110 per 1 lakh population 
in 20-40 years age group. Overall incidence of typhoid fever varies 
between 266 to 980 per 100,000 person years.  
Typhoid fever incidence higher in school going children and young 
adults. Highest incidence is seen in those aged below 15 years and is 
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considerable even between ages of 1 to 5 years. It has no racial 
predilection.  
HABITAT 
 Salmonella typhi is primarily an intestinal pathogen of human 
gastro intestinal tract. It is found often in sewage, river and in soil in 
which S.Typhi do not multiply considerably. It has been recovered from 
foods such as vegetables and fruits and are main contaminants of animal 
protein-feed supplements. It is capable of thriving in hostile environments 
such as ice, dust, clothes and water38. 
PHENOTYPE 
Salmonella typhi is a gram negative rod , non spore forming, non 
capsulated, aerobic but facultatively anaerobic bacilli and measures about 
2 to 3 by 0.4 to 0.6 microns in size.It is motile as a result of peritrichous 
flagella38.  
RESISTANCE 
S.Typhi resistant to certain chemicals (sodium tetrathionate and 
brilliant green) that restrains other bacteria so it will be useful to 
incorporate them in culture media to recover S.Typhi from faeces. It will 
survive in sewage water for weeks, in ice for months, in soil for years 
under suitable conditions. It can be killed by heating to 54.40 C for 1 
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hour, 600 C for 1/4th hour. S.typhi can be killed by boiling and 
chlorinating the drinking water. It is readily killed by 5% phenol within 5 
minutes. Recent studies revealed various genes (Pho P/Pho Q, Omp R, 
env Z) responsible for the ability of S. typhi to adapt in environmental 
changes such as changes in pH, osmolality, changes in calcium 
concentration and to withstand effects of microbicidal proteins such as 
defensins present in the phagosomes of the phagolytic cells. The S. typhi 
can acquire R plasmids which enable them to develop resistance against 
chloramphenicol, amoxycillin, cotrimoxazole. 
STRUCTURE OF ANTIGENS 
The following antigens were used to describe the serological 
characteristics of S. typhi. 
1. The O antigens, heat stable polysaccharides which makes a 
portion of cell wall lipo polysaccharide . This is determined by slide 
agglutination test. This is less immunogenic than the H antigen, hence 
produces titres less than H antigen following immunisation or infection. 
When mixed with antisera it produce compacted, chalky, granular 
clumps. 
2. The H antigens are heat labile proteins of the flagella which have 
diphasic variation. It is determined by the tube agglutination test. The H 
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antigen is responsible for strong immunogenic response by S. typhi, 
provoke antibody formation quickly and in high titres following infection 
and vaccination. When mixed with antisera rapidly produces large, loose 
and fluffy clumps39. 
3. Surface Vi antigen 
 Vi ANTIGEN 
 Vi is a capsular polysaccharide of alpha-(1-4) linked N-acetyl-D-
galactoseaminouronic acid randomly acetylated at C2/C3 positions. It 
protects from immune serum mediated killing, is anti-phagocytic and 
responsible for resistance to peroxide radicals. The virulence to the 
S.typhi is provided by the Vi surface antigen. Vaccines for typhoid fever 
targets this Vi antigen39.  
Vi surface antigen has no inherent virulence mechanisms, but 
offers virulence by disguising the oligosaccharide O antigen from 
immunological mediated attacks. It acts by coating the surface of the 
organism, thus avoiding antibacterial and opsonin effect of the O 
antibody. Being poorly immunogenic, allows only low titre antibody 
production following infection. Detection of Vi antibody is not helpful to 
diagnose the typhoid fever. Persistence of Vi antibody points toward 
carrier state.  
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CULTURE CHARACTERS AND GROWTH REQUIREMENTS 
S.Typhi grow within temperature range from 7-48 degree celcius 
and pH ranging from 4-8. It multiplies at 430 C in an enrichment medium 
like bismuth-sulphite medium. Wilson Blair is a suitable selective media 
for S. typhi39. 
Blood agar: On blood agar, S.typhi and S.paratyphi usually forms non-
hemolytic smooth white colonies. 
MacConkey agar: On MacConkeyagar , it produces lactose non-
fermenting smooth colonies. Colonies will have a distinctive vine leaf 
pattern.  
Salmonella-Shigella agar: On SS agar S. typhi forms lactose non-
fermenting colonies with black centre. 
Desoxycholate agar: as in SS agar, it forms lactose non fermenting 
colonies with black centre.  
Xylose-lysine-desoxycholateagar: On Xylose-lysine-desoxycholate agar, 
S. typhi forms transparent red colonies with black centre. 
Hektoen enteric agar: On hektoen enteric agar, S. typhi will form 
transparent green colonies with black centre38.  
BIOCHEMICAL CHARACTERISTICS 
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1. S. Typhi does not produce gas on sugar fermentation with glucose, 
maltose, Mannitol and Sorbitol but produces only acid. 
2.  Lack of fermentation with sucrose, lactose, salicin and adonitol. 
3.  On cytochrome oxidase test it gives negative result. 
4.  Gives positive test on catalase reaction. 
5.  Reduces nitrates to nitrites in nitrite reduction test. 
6.  On Phenylalanine deaminase test fail to deaminate Phenylalanine. 
7.  Indole negative. 
8.  Produces positive reaction on methyl red test. 
9.  Acetoin not produced with vogue proskaeur test. 
10.  It does not produce urease. 
11.  Citrate not utilized when reacting with simmons citrate. 
TRANSMISSION 
Enteric fever principally spreads through faeco-oral route by 
ingestion of food or water contaminated with faeces. Transmission can 
occur directly through soiled hands contaminated with faeces or urine of 
cases or carriers or indirectly through contaminated water, milk, food and 
also through flies40. 
SOURCE OF INFECTION  
Humans are the only natural host and reservoir for S. typhi. It is 
either patient or carriers. The infectious dose ranges between 103 and 106 
organism taken orally1. 
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Cases: cases may be mild, missed, or severe. A case or carrier is 
infectious until he excrete the organism in urine or faeces40. 
Carriers: They can be temporary (convalescent or incubatory) or 
chronic. Patients will excrete the bacilli in urine or stool for about a 
month40. 
Convalescent carriers –Patient will excrete the S.typhi for 6-8 
weeks after which the number of bacilli in stool declines. By the end of 
3rd month only 4% of patient will excrete the bacilli. At the end of 1 year 
average carrier rate is around 3%39. 
Chronic carriers –This state is defined as seepage of organism in 
urine or stools for more than a year.1% to 5% of enteric fever patients 
will become carriers. Risk factors were female sex, age more than 50 
years, presence of gall stones, schistosomiasis, carcinoma of the gall 
bladder and other GIT cancers. Generally bacilli persists in the gall 
bladder or biliary tract. Carriers may excrete the organism for several 
years as long as 50 years. The famous typhoid Mary is a well known 
example for chronic carrier. She was presumed to have infected 53 
persons, 3 of them died due to enteric fever, over the course of her carrier 
as a chef in hotel. She was isolated for nearly 30 years by U.S. public 
health department. 
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( Typhoid Mary in a 1909 newspaper illustration. Note the skulls she 
casts into the skillet)  
RISK FACTORS FOR INFECTION 
The S.Typhi could continue to exist for days in ground water, pond 
water and sea water, for months in contaminated eggs and oysters. Well-
known risk factors were contaminated water supply, ice cream, flavoured 
ice drinks, food from street vendors, raw fruits and vegetables grown in 
fields fertilized with sewage. 
Other risk factors includes a history of contact with enteric fever 
cases, poor hygiene, poor housing, over crowding, infection with 
H.pylori, open air defecation and urination and neglected food hygiene. 
Consequently typhoid fever incidence can be considered as an measure of 
general sanitation in any country28. 
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INCUBATION PERIOD 
This is generally 7-14 days but varies between 3-30 days1. It 
primarily depends on infecting dose. Hosts health and immune status also 
influence incubation period. The inoculam volume and type of vehicle 
with which bacilli ingested influence the attack rate and incubation 
period1.  
IMMUNITY 
 Antibody production can be induced by infection or vaccination. 
Large amount of antibody to somatic antigen O is formed as a reaction to 
infection in contrast to flagellar H antigen. Likewise large amount of 
antibody to flagellar antigen H is formed as a reaction to immunization in 
contrast to somatic O antigen. Antibodies to somatic antigen O or 
flagellar H antigen are not primary defence mechanisms. Since S.typhi is 
an intracellular organism cell mediated immunity had a major role in 
immunity. An attack does not produce permanent immunity. Re-infction 
may occur if large amount of bacilli ingested again. Gastric acidity and 
local intestinal immunity are main defence mechanisms to lower the 
susceptibility to infection. Specific IgD and IgA antibodies had been 
identified in intestinal local mileu of infected persons39. 
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PATHOGENESIS1 
After being ingested, the bacilli enters into intestinal cells by attach 
themselves to special type antigen sampling cells, called as M cells that 
cover the gut associated lymphoid tissues , through enterocytes or 
through a paracellular route. The bacilli overcome the gut mucosal barrier 
after getting attatched to microvilli by a complex process involving 
membrane ruffles, actin rearrangement and internalization in an 
intracellular vacuole. S. typhi have the virulence factors for down 
regulating the pathogen recognition receptor mediated host inflammatory 
response. Within the peyers patches of the terminal ileum, the bacilli 
overcome the gut barrier by following mechanisms, including the M cells 
in the follicle associated epithelium, epithelial cells and dentritic cells1. 
Immediately after contacting the epithelium, organism gather the 
TTSS-1. Then it translocates effectors into cytoplasm of enterocyte. This 
effectors can stimulate the host Rho guanosinetriphosphatases (GTPases) 
leading to actin cytoskeleton reorganization and membrane ruffling. The 
effectors also induces mitogen activated protein kinase (MAPK) 
pathways and destablization of the tight junctions1. The uptake is 
facilitated by modifications in the actin cytoskeleton brought by actin 
binding proteins Sip A and Sip C. The destabilization of tight junctions 
leads to transmigration of neutrophils from the basolateral surface to 
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apical surface, paracellular fluid leakage, movement of bacteria to 
basolateral surface. It is followed by internalisation organism by 
macropinocytosis, enclosed in a large phagosome which is created of 
membrane ruffles. Then this phagosome fuses with lysosomes, acidifies 
and shrinks to form a adherent membrane around the S.typhi, thus 
completes the making of Salmonella containing vacuole (SCV). TTSS-2 
initiation leads to translocation of effector proteins (Sif A, PipB2) 
necessary for Salmonellae induced filament (Sif) formation by the side of 
microtubules. 
 After crossing the intestinal mucosa, S. typhi go into in to the 
mesenteric lymph nodes and enter into the bloodstream via the 
lymphatics (through thoracic duct).This primary bacteremia is 
asymptomatic. The blood-borne bacteria were disseminated throughout 
the body. They colonize the organs of RES, in which they replicate within 
macrophages. Thus within 24 hours of entry, S.typhi begins its replication 
in an intracellular mileu of reticuloendothelial system organs like spleen, 
liver, bone marrow etc. After replication, i.e. incubation period, organism 
are released back into the blood, leading to secondary bacteremia 
marking the commencement of symptoms. This secondary bacteremia is a 
sustained one and having 1-10 bacteria per ml of blood. 
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The capability of S. Typhi to survive within macrophages after 
phagocytosis is an significant virulence factor to set up systemic 
infection. This trait encoded by the PhoP regulon in the genome of 
S.typhi. The TTSS-2 and the surface Vi polysaccharide capsular antigen 
were the important virulence factors of the organism to cause systemic 
infection. Later one prevents the binding of C3 to the surface of 
bacterium, thus interfering with phagocytosis. 
TABLE 1 : FACTORS RESPONSIBLE FOR SUSCEPTIBILITY 
TO S. TYPHI INFECTION 41 
Sickle cell anemia  Reticuloendothelial system overload 
owing to hemolysis,  
Functional asplenia, 
Tissue infarcts  
Defective opsonization. 
Neutropenia (congenital or acquired ) Polymorphonuclear neutrophils needed 
for killing  
Chronic Granulomatous disease  Defective killing by polymorphonuclear 
neutrophils  
AIDS Low CD4  
Effects of Malnutrition on cell mediated 
immunity  
Survival of organism in macrophages 
(owing to salmonella genes PhoP/PhoQ, 
spvA-D,R) 
Organ transplantation , 
immunosuppression  
Defective cell mediated immunity  
Gastrectomy Loss of stomach acid barrier  
Malaria  Reticulo endothelial system overload 
owing to hemolysis  
Abnormal complement levels  
Abnormal macrophage function  
Bartonellosis Reticulo endothelial system overload 
owing to hemolysis 
Schistosomiosis Salmonella sequestered in schistosomes 
protected from host defenses and 
antibiotics  
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TABLE 2 : PUTATIVE PATHO PHYSIOLOGICAL BASIS OF 
SELECTED CLINICAL FEATURES OF S. TYPHI INFECTION41 
 Disease manifestation  Mechanism and bacterial genes  
Bloody diarrhea  sip A-D mediated invasion and intereukin 8 
mediated inflammation  
Watery Diarrhea  stn enterotoxin (cholera like toxin) 
SopB- mediated intestinal inflammation and 
fluid secretion  
Serotype that induce transepithelial 
polymorphonuclear lecocyte migration are 
more likely to cause diarrhea than are 
serotypes that do not. 
Bacteremia  ViaB (Vi synthesis ) Capsular antigen 
interferes with C3 binding,  
rck resistance to serum complement 
(virulence plasmid encoded ) 
rfb encodes lipopolysaccharides synthesis , 
lipopolysaccharide contributes to persistence 
of bacteremia  
Relapses , prolonged fever , failure of 
certain antibiotics 
Survival in macrophages (sseABC, spiC, 
mgtCB , cyototoxin and virulence plasmid 
genes spvRABCD) 
 
PATHOLOGICAL CHANGES 
Typhoid fever is primarily an infection of hematopoietic system. 
The mononuclear cell hyperplacia is the important microscopic feature. 
Typhoid nodules are characteristic. It leads to lymphadenopathy, 
splenomegaly and enlargement of lymphoid tissues in the intestine 
especially the terminal ileum (peyers patch). The mononuclear 
hyperplacia may also be observed in bonemarrow, liver and lung38. 
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CHANGES IN THE INTESTINE 
Peyers patches are lymphoid aggregates seen in the terminal 
regions of small intestine. Payers patches are invaded by the organism, 
during primary inestinal infection or during secondary bacteremia, further 
seedling occurs through infected bile. This leads to hyperplacia and 
infiltration with chronic inflammatory cells later necrosis of superficial 
cells resulting in development of irregular, ovoid ulcers along the long 
axis of intestine so that stricture will not form when healing occurs. When 
underlying blood vessels eroded by this ulcer, it may lead to severe 
bleeding. A transmural perforation may lead to peritonitis. This ulcers are 
very shallower in children than in adults. So, both bleeding (<1%) and 
perforation (0.5 to 1%) are rare in children. 
The lymphoid follicles in the caecum, jejunum, proximal colon and 
appendix also get involved resulting in swelling and hyperemia of this 
lymphoid organs. The main feature in all these lesions is lack of 
polymorphonuclear leucocyte invasion. Inflammation, increase in 
sinusoids and enlargement also seen in mesenteric lymph nodes. 
CHANGES IN THE LIVER42 
 Liver becomes enlarged and swollen. There are areas of focal 
necrosis resulting in tiny nodules. Histopathology of liver shows typhoid 
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nodules, cloudy swelling, ballooning degeneration, moderate fatty change 
and macrophages in the sinusoids. In addition, intact S. typhi bacilli have 
been demonstrated in the parenchyma of the liver by doing immuno 
histochemistry and have been cultured from liver biopsy. The liver 
lesions seen microscopically mimics the picture of acute viral hepatitis.  
CHANGES IN GALL BLADDER 
The infected bile render the stool culture positive. Acute 
cholecystitis occurs rarely. Preexisting gallbladder disease leads to 
chronic infection, resulting in chronic fecal carriage. Chronic 
cholecystitis and gall stones are frequent associations with carrier state. In 
vast majority of cases, infection of the bile terminates spontaneously 
during convalescence peroid. 
CHANGES IN THE SPLEEN 
Proliferation of splenic cells, of splenic sinusoids and pulp results 
in soft enlargement of spleen. Capsule also becomes tense. Focal areas of 
necrosis can be seen microscopically. Rapid enlargement can results in 
rupture and splenic hemorrhage. Splenic abscesses are observed 
occasionally. 
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RESPIRATORY SYSTEM 
Bronchitis is the commenest form of respiratory tract involvement1. 
Rarely lobar pneumonia, empyema, pleurisy were observed. 
CHANGES IN BONE MARROW 
The lesions in the bonemarrow contains large number of 
phagocytic cells which are derived from histiocytic members of 
reticuloendothelial system34. They result in leucopenia, which is more 
common in adults than in children. Children frequently have leucocytosis. 
Bone marrow culture is gold standard for diagnosing typhoid fever. They 
increses the yield in detection of S.Typhi. 
CENTRAL NERVOUS SYSTEM CHANGES 
Neurological involvement is relatively infrequent in children. The 
word typhos in Greek language means smoke. It is said to indicate the 
clouding of consciousness associated with fever. Encephalopathy, 
meningitis, intracerebral hemorrhage and spinal cord involvement can 
occur36.  
CHANGES IN THE KIDNEYS 
Clumps of organism can be seen in the glomeruli as well as in 
urine microscopically. Immune complex glomerulonephritis also have 
been reported in literature. 
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CHANGES IN THE HEART  
Subacute bacterial endocarditis may occur in patients with 
preexisting valvular heart disease. Arrythmias, sinoatrial block can occur. 
The relative bradycardia, i.e. lower pulse rate out of proportion to fever is 
uncommon in children. It is due to effect of toxins on the myocardium. 
CHANGES IN THE BONE 
Bone can be involved in the form of periosteitis and osteomyelitis. 
Periosteitis is common in tibia and ribs. Bone abscesse seen infrequently. 
CHANGES IN THE MUSCLE 
Zenkers degeneration (waxy degeneration) can be seen in muscles. 
Frequently involved muscles are the diaphragm, rectus abdominis and the 
intercostals and thigh muscles. 
CHANGES IN THE SKIN 
Rose spots can be seen in skin, which are due to bacterial 
embolisation. Rose spot culture is also a diagnostic tool, their culture may 
be positive. They are not only for typhoid fever, can also be seen in 
infections with shigella and non typhoidal salmonellosis. 
CLINICAL FEATURES 
The clinical features fever may vary depending on the age of the 
patient.. The clinical spectrum ramnges from a mild febrile illness with 
low grade fever, malaise, and dry cough to a lethal disease due to 
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multiple complications. The severity and outcome of the infection 
depends on the duration of the fever before starting treatment, 
antimicrobial agent used, age of the patient, previous exposure, 
immunization status, virulence of the strain, size of the inoculam 
ingested, immune status, HLA type and history of concomitant drug 
intake like H2 receptor blockers. People living with HIV and AIDS are at 
increased risk for typhoid fever. World Health organization classifies 
presentation of typhoid fever into three categories, acute non complicated 
disease, complicated typhoid fever and carrier state. 
ACUTE NON COMPLICATED DISEASE 
Protracted fever, diarrhoea, headache, malaise, loss of appetite 
characterizes the acute non complicated disease. Dry cough due to 
bronchitis is common in early stages3.  
COMPLICATED DISEASE 
Typhoid fever can be a severe disease in upto 10% of patients. 
Presence of occult blood in stool can be seen in 10-20% of patients 3% 
may have melena. This group also comprises GI perforation, peritonitis, 
hepatitis, toxic myocarditis, DIC, neurological sequelae like delirium, 
Gullain-Barre syndrome. They are described in detail below3. 
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CARRIER STATE 
 This state develops in 1-5% of patients. Mostly they harbor the 
bacilli in their gallbladder. The chronic carrier state is defined as 
persistence of S.typhi in urine or faeces for a period > 3 months in 
children. The risk for chronic carrier state in children is low (less than 2% 
for all infected children) and increasing with age. A chronic urinary 
carrier state is observed with coexisting urinary bladder infection of 
schistosoma hematobium. Serology for the Vi antigen differentiates 
chronic carrier state from acute infection with S. typhi, as chronic carriers 
have the high level of antibodies against this antigen.  
SYMPTOMS AND SIGNS 
Enteric fever presents as high grade fever with different features 
like myalgia, abdominal pain, hepatomegaly, splenomegaly and loss of 
appetite. Children can have the loose stools in early stage and may be 
followed by constipation. It is difficult to differentiate the typhoid fever 
from other endemic infections like malaria, dengue fever, leptospirosis 
and acute viral hepatitis in the early stages of typhoid fever. 
Typhoid fever may present atypically where malaria and 
schistosomiosis were endemic. The multidrug-resistant S.typhi infection 
is more severe than chloramphenicol sensitive typhoid in terms of higher 
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toxicity, complications, and case fatality rate, because of greater virulence 
and increased numbers of circulating organisms. Nalidixic acid resistant 
and fluoroquinolone resistant strains are associated with more morbidity 
and treatment failure1. 
 Classical step-ladder pattern of typhoid fever is increase in the 
temperature by about 20 F during evening times and falls about 10 F 
during morning times, so that at the end of 5 days reaching a plateu of 
between 102 and 104 0F above which it rarely ascends. But this step-
ladder pattern is rare in children. There are studies showing 60% patients 
had continuous fever and rest had intermittent, remittent or irregular 
fever. Fever is frequently associated with frontal headache. Relative 
bradycardia or pulse temperature dissociation is rare in children. 
Malaise is a typical presenting symptom in typhoid fever. Chills is 
another characteristic symptom but rigors are uncommon.  
Headache is persistent rather than severe. Occasionally headache 
may severe enough to suggest meningitis. Myalgia and arthralgia are 
common. Abdominal pain may be so severe so as to mimic acute 
appendicitis. 
Many patients presents with cough and during the first week of 
illness it closely resembles acute bronchitis. Generally the appetite is 
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poor. Diarrhoea is a common symptom in early presentation. “Pea soup 
diarrhoa” occurs during the third week of fever and it contains the red 
blood cells, not the frank blood. Severe diarrhoea has been reported in 
HIV patients with typhoid. Alternatively constipation can be seen during 
first week, but it is more common in adults. Presence of constipation is 
associated with higher relapse rate. 
 Tongue becomes coated with white or brown coating which spares 
the tip and edges and may have musty damp-hay like odour41. Rose spots 
are salmon coloured macular or maculo-papular exanthem which may 
appear in crops around 7th to 10th day of fever. Their number is around 
10-15, visible on the lower chest and abdomen and lasts around 2-3 days 
then gradually disappear leaving a brownish stain. Often they are only 4 
or 5 spots, more than 20 spots is regarded as profuse rash. They disappear 
on pressure, ranging in diameter of 2-4 mm and not easy to observe in 
dark skinned children1. 
 Around the 7th to 10th day of fever a soft splenomegaly can be 
noticed. The splenomegaly is mild, just palpable or upto 3 cm below the 
left costal margin. Hepatomegaly may be detected as early as first week, 
but commonly during the second and third weeks of fever and took 
several weeks to disappear. Jaundice is noted in around 16% of patients.  
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 By the end of 2nd week the patient will become profoundly ill, 
unless the course is modified by antibiotics. During the 3rd week increase 
in toxemia, hepatosplenomegaly, intestinal bleeding, perforation due to 
ileocaecal lymphatic hyperplacia of the peyers patches may occur, 
together with secondary bacteremia and peritonitis. Septic shock or an 
altered level of consciousness may develop. patient may become 
comatous and die. In the absence of acute complications or death from 
overwhelming gram negative sepsis, symptoms gradually resolve over 
weeks to months. 
 “Coma vigil” or muttering delirium is state where the patient is not 
unconscious but not conscious of anything, confused, sleepless and 
disoriented. The patient lies in the bed with open eyes but oblivious of 
surroundings. This state can be seen if the patient was not treated 
properly and when he reaches the third week. 
 The face may reflect profound toxemia and becomes 
expressionless, shunken, shallow and a flush over the cheek bones that 
will spread as the illness worsens. The famous clinicians Louis and Osler 
described the appearance typhoid fever patient during the advanced stage 
of the disease as follows;”muttering delirium, twitching of fingers and 
wrists (sub sultustendium), agitated, plucking at the bed clothes 
(carphology), staring, unarousable stupor (coma vigil). 
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 Following recovery, up to 5% of patients become chronic carriers. 
The mortality rate is less than 1% if correct treatment is given. It is 
around 20-30%, if not treated. The most important reason for poor 
outcome is almost certainly a delay in starting antibiotic treatment. 
 Relapse rate in typhoid fever is usually around 2 to 4%.Inspite of 
this high relapse rate, reasons for relapse is largely unknown. Relapse is 
said to be present with the recurrence of clinical signs and symptoms, 
culture proven infection with S. typhi, with an antibiogram identical to 
the original isolates, within 8 weeks of cessation of successful treatment 
of initial infection. Relapses typically occur 2 to 3 weeks after the 
defervescence of fever and milder than the previous illness. The early use 
of effective antibiotics may be the cause for increase in relapse 
presumably because early appropriate antibiotic treatment prevents the 
development of adequate immune response. 
 Typhoid fever varies in its clinical course. Variations in the classic 
theme includes41 
1.  A completely afebrile course can be seen in debilitated children 
2.  High spiking fever from the first day of fever (particularly in 
younger children) 
3.  A focal presentation (e.g. pneumonia, nephritis) 
4.  A severe course during relapses. 
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Typhoid fever has the following differences in the clinical picture 
when presenting in young children than older children. 
 Respiratory symptoms and signs are seen more often 
 Diarrhoea is frequent in young children, whereas constipation is 
more often seen in older children. 
 Relative bradycardia is unusual in young children. 
 Perforation is less common in young children. 
 Leucopenia may not always occur.  
The differential diagnosis of typhoid fever includes Dengue fever, 
leptospirosis,  acute viral hepatitis, acute viral fever, ricketsiosis. 
COMPLICATIONS OF TYPHOID FEVER 
Since typhoid fever is a multisystem disease, complications have 
been reported in every system of the body. Complications occur in 10 to 
15 % of patients. Most of them develop during second or third week of 
fever. 
GASTROINTESTINAL COMPLICATIONS 
The most common complications of typhoid fever are related to 
gastrointestinal tract. Paralytic ileus and abdominal distension being the 
most frequent manifestations in GIT. The intestinal perforation and 
severe gastrointestinal hemorrhage are the another two most dreaded 
complications8. 
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1. INTESTINAL HEMORRHAGE 
 During the first week itself, there may be evidence for 
hemorrhage. Occult blood in stools is detected in 10-20% of patients, 3% 
have melena. During the second to fourth week of illness, in less than 1% 
of children severe hemorrhage can result from erosion of blood vessels in 
the peyers patches due to ulceration. When the amount of hemorrhage is 
greater, there will be a thready pulse, signs of collapse1. The incidence of 
hemorrhage is more than perforation. Hemorrhage generally occurs from 
multiple, variable sized punched out ulcers in the distal ileum and 
proximal colon. It is infrequent in children.  
2. INTESTINAL PERFORATION 
The perforation has been reported in up to 0.5 to 1% of 
hospitalized patients. This also rare in children and usually occurs during 
second to fourth week of illness. Perforation may be preceded by marked 
increase in abdominal pain (usually in the right lower quadrant), 
tenderness, vomiting and signs of peritonitis. A rapid decline in 
temperature late in the illness should arouse suspicion of perforation; 
such a decline in temperature classically followed by an increase a few 
hours later as peritonitis develops3. 
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Intestinal perforation and peritonitis are accompanied by 
tachycardia, hypotension, abdominal tenderness and guarding and 
ensuing abdominal rigidity, absence of bowel sounds, loss of liver 
dullness .A rising WBC count with a left sided shift and 
pneumoperitoneum on abdominal X ray erect view, were frequent 
findings. 
The perforation size may range from pinpoint to several 
centimeters, mostly occur at the lower end of ileum. Gram negative sepsis 
may ensue. In three quarters of cases it is single perforation and 
associated with high mortality rate. Inadequate antibiotic treatment, male 
sex and leucopenia have been found to be independent risk factors for 
intestinal perforation. 
3. PARALYTIC ILEUS 
In typhoid fever abdomen may be tender, doghy in consistency and 
with slight guarding. Distension also may be a part of illness. But when it 
is greatly distended with tenderness and severe vomiting it indicates 
paralytic ileus or meteorism. Paralytic ileus is due to severe toxemia, 
severe intestinal lesions with or without peritonitis and hypokalemia. 
HEPATIC COMPLICATIONS11 
Abnormal liver function test is observed in many children with 
typhoid fever. Clinically significant hepatitis, jaundice and cholecystitis 
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are rare in children. The prevalence of hepatobiliary complications is 
between 1-26%.Risk factors were dwelling in endemic region, splenic 
trauma, HIV, hemoglobinopathy. 
The presence the of jaundice in children with typhoid fever is 
associated with higher rates of mortality and morbidity. Jaundice is a rare 
presentation in enteric fever and if present it may lead to diagnostic 
problems, especially in the tropics where malaria and viral hepatitis are 
common. There are several reports that have been made about typhoid 
hepatitis. The incidence of jaundice in typhoid fever ranges between 4.8% 
and 17.6%. Jaundice usually manifests about 1 week from the onset of 
fever and improves slowly with recovery of illness. Jaundice can occur in 
the absence of liver enlargement. Jaundice mostly results from conjucated 
hyperbilirubinemia and it is due to hemolysis and impaired excretion as a 
result of canalicula occlusion by swollen hepatocytes. This impaired 
excretion followed by focal hepatocellular necrosis which leads to rupture 
of bile canaliculi resulting in direct reflux of bile into the hepatic 
sinusoids, hence the predominant elevation of conjucated bilirubin. 
Typhoid fever should be considered in any febrile child who develops 
jaundice about one week after the onset of fever with or without 
hepatomegaly. 
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 Liver function test may show the hepatic dysfunction even in the 
absence of icterus. A significant rise in serum bilirubin without a parallel 
increase in serum ALT is unusual in viral hepatitis but a common finding 
in enteric fever. Elevated liver enzymes can be seen in 21 to 60% of 
cases. Mild elevation of serum transaminases (upto 3 times above the 
normal) can be noted in around 60% of typhoid fever children and is four 
times more common than moderate elevation (3-20 times above the 
normal). This biochemical evidence of liver dysfunction is due to 
invasion of S. Typhi in to liver and high concentration of toxins that 
damage the liver cells. The S.Typhi proliferates in the liver cells and 
leads to hepatic damage by stimulating the synthesis and release of 
cytokines.  
GALL BLADDER 
Gall bladder may be involved in the form of acute cholecystitis, but 
it is very rare. Involvement may range from mild catarrhal type to 
dangerous perforation of gall bladder, mostly occurs around the end of 
second week. Gall bladder may harbor the bacilli, leading to chronic 
carrier state. 
CNS COMLICATIONS36 
 These are relatively rare in children. Neurological manifestations 
are associated with high case fatality rate. But usually the recovery is 
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associated with no permanent sequelae. Their prevalence is between 3 to 
35%. Identified risk factors include living in the endemic region, 
malignancies, sinusitis, foci in the lung and osteomyelitis of the skull.  
 A wide variety of neuropsychiatric manifestations can occur and 
includes, delirium, psychosis, increased intracranial pressure, acute 
cerebellar ataxia, chorea, deafness, guillain-barre syndrome, meningism, 
meningitis, convulsions, encephalopathy, cerebral edema, subdural 
empyema, cerebral abscess, ventriculitis, transient parkinsonism and 
motor neuron disorders. 
TYPHOID MENINGITIS 
S. Typhi should be considered in the differential diagnosis of gram 
negative bacillary meningitis, in children of the endemic populations29. It 
is more common in young children, neurological symptoms and signs 
will not be apparent. Seizures and coma were the most frequent 
presentations. S.typhi can be recovered from cerebrospinal fluid. The 
main findings in the CSF biochemistry is increased leucocytes, increased 
proteins and low glucose determinations. The mononuclear cells will 
predominant than polymorphs. Thus CSF features might look like viral 
meningitis and can be distinguished by means of culture method. 
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HEMATOLOGICAL COMPLICATIONS 
These include anemia, disseminated intravascular coagulation, 
leucopenia, eosinopenia, thrombocytopenia35. Other observed rare 
sequelae are fatal bone marrow necrosis, hemophagocytosis syndrome1. 
 Anemia in typhoid fever may be due to blood loss from intestinal 
lesions or hemolysis or defective production of RBC in the bone marrow. 
The bone marrow histology reveals myeloid maturation arrest, decrease 
in the number of erythroblasts and megakaryocytes with increased 
phagocytic activity of histiocytes. Acute hemolytic anemia and 
hemoglobinuria have been reported. Patients who have thalassemia and 
glucose-6-phosphate dehydrogenase deficiency may have hemolysis 
during typhoid fever. 
 In younger children leukocytosis is frequent and may reach 20000 
to 25000cells/mm3.Thrombocytopenia may indicate a severe infection 
and usually accompanies the disseminated intravascular complication. 
RESPIRATORY COMPLICATIONS 
Respiratory symptoms of enteric fever, such as cough occur in 11 
to 86% of patients. Pneumonia, empyema and bronchopleural fistulas 
seen in 1 to 6% of cases.A case of massive pulmonary embolism in the 
course of pneumonia of typhoid fever has been reported. Patients with 
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lung involvement of typhoid fever frequently have lung anamolies, prior 
history of lung infection, sickle cell anemia, and immune suppression due 
to HIV infection. 
 Patient may present with fever, chills, cough (with or without 
expectoration), pleurisy, coarse crackles and bronchial breathing on 
auscultation, diarrhoea and leucopenia. Chest X ray findings observed in 
24% of children with features of bronchitis and pneumonia. S.typhi is 
very rarely isolated from the sputum42. 
 When comparing to lobar pneumonia, brochopneumonia is more 
common in children. Sympathetic bilateral pleural effusion and 
pneumothorax have been reported. Pneumonia occurs in the second or 
third week of illness. Cases of acute respiratory distress syndrome 
(ARDS) have been reported and it is associated with very high mortality. 
Other complications are tonsillitis and pharyngitis. 
CARDIOVASCULAR COMPLICATIONS 
 The prevalence of cardiovascular system involvement is between 1 
to 5%. Most of the children with cardiac complications have underlying 
cardiac problems like preexisting valvular diseases, RHD and birth 
defects of heart. Cardiovascular complications may manifest as 
asymptomatic electrocardiographic changes, toxic myocarditis presenting 
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as arrythmias, sinoatrialblock, cardiogenic shock and infection of 
prosthetic valve. 
 Pericarditis and arteritis noted in < 1% of cases. Sustained 
bacteremia may result in an increased tendency for this organism to 
attach to endovascular compartments, including atherosclerotic 
aneurysms42. One study reveals cardiac arrythmias can occur in 3% of 
patients. ECG features has no are no diagnostic value and may reveal 
nodal tachycardia, A-V dissociation with narrow QRS complexes, and/or 
non specific ST segment changes. Echocardiogram might reveal 
vegetations. A transesophageal echocardiography has a greater sensitivity 
when comparing with a transthoracic 2 dimensional echocardiogram to 
identify the valvular dysfunctions and vegetations. 
The incidence of toxic myocarditis is high with MDRST infection. 
Case report of venous thrombosis involving leg veins reported by 
J.B.Gosh from west bengal in a 9 year old girl. 
MUSCULO SKELETAL COMPLICATIONS 
Focal suppurative infection with S.typhi can occur almost 
anywhere. Most common sites are bone (particularly in sickle cell 
anemia) and central nervous system. Involvement of bone and joint in 
children is very rare, prevalence is less than 1% only. Risk factors include 
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type 1 diabetes, systemic lupus erythematosus, lymphoma, liver diseases 
and steroid use. 
Osteomyelitis due to S. Typhi can result from one of the three 
mode of spread; blood borne spread, contiguous spread or as due to 
vascular insufficiency42. Of these, hematogenous spread is commonest. 
The sites commonly involved are the diaphysis of long bones such as the 
proximal humerus, distal femur and distal tibia. Less common sites 
includes the spine, the sternochondral junctions ,radius, ulna, sternum, 
ribs, sternoclavicular joints and cranium. Cases of septic arthritis have 
been reported. Patient may present with fever, swelling and arthralgia 
with or without effusion. Investigation may reveal elevated WBC count. 
Aspiration of the joint fluid is essential for diagnosis of S.typhi arthritis. 
A leucocytosis (>50000 lecocytes /ml) and lowered glucose (< 50% of 
the plasma glucose concentration) of the joint fluid indicates septic 
arthritis. 
GENITOURINARY SYSTEM COMPLICATIONS 
These complications are rare, even in endemic areas. Prevalence is 
less than 1%.Chronic urinary carriers can be seen in endemic areas. In 
areas where Schistosoma hematobium infection is endemic, this urinary 
carriers may have an active co- infection with schistosoma hematobium39. 
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 Predisposing factors include congenital anomalies, calculi or 
obstruction, pyelonephritis, dermoid cyst and renal transplant. In a case 
series report f 18 patients with urine culture confirmed infections, almost 
80% of patient had symptoms of fever, dysuria, incresed frequency and 
suprapubicpain. Urine routine examination of these patients revealed the 
pyuria in 94% of patients and proteinuria in 91% of patients.The 
diagnosis is established by urine culture method, detection of 105 CFU 
per ml of urine. 
Hemolytic –uremic syndrome, pyelonephritis, nephrotic syndrome, 
orchitis are other reported complications. 
MISCELLANEOUS COMPLICATIONS 
Rarely patient may develop immune complex glomerulo nephritis 
and irreversible loss of renal function has not been reported. One case of 
cutaneous vasculitis has been reported. Skin biopsy in this patient shown 
leucocytoclastic vasculitis with superficial and deep perivascular infiltrate 
of lymphocytes and neutrophils and C3 deposits in dermal vessels.  
 5 cases of haemophagocytosis has been reported in 
literature.These patients presented with fever, lymphadenopathy, 
hepatosplenomegaly, pancytopenia, coagulopathy, hepatitis, jaundice and 
hyperferritinemia. Bone marrow was hypocellular and reduced 
38 
 
megakaryocytes, myeloid precursors and erythroid precursors. A gram 
stain of bone marrow culture proving S.typhi infection is required for 
establishing the diagnosis of haemophagocytosis in typhoid fever. 
Parotitis and parotic abscess cases due to S.typhi reported. Typhoid 
rhabdomyolysis with acute renal failure and pancreatitis has been 
reported from vietnam in a 15 year old male. 
Yacaman-Handal et al from spain reported a case of acute 
pancreatitis in a pre- school child. Many cases of suppurative 
lymphadenitis and abscesses due to S.Typhi have been reported. Caksen 
et al described a case of 12 year old boy with splenic abscess and pleural 
effusion due to S.Typhi. Splenic abscess is very rare in typhoid fever. 
LABORATORY DIAGNOSIS OF TYPHOID FEVER 
Clinical diagnosis of typhoid fever is not easy, due to absence of 
specific clinical signs. The mainstay of diagnosis is isolation of S.Typhi 
from the blood or other specimens. Culture of the S. Typhi may be 
obtained from stool, urine, blood, bone marrow, bile and from rose spots. 
Of these culture of the bone marrow has the highest yield, particularly if 
the patient has been treated with antibiotics earlier. But bone marrow 
aspiration is tricky and invasive one. 
39 
 
Stool culture may be sometimes positive during the incubation 
period. During the first week of typhoid fever, approximately 40 to 60 
percent of patients have positive blood and urine cultures. During the 
subsequent weeks , the yield of blood culture decreases as the yield of 
stool and urine culture increases. Culture of duodenal fluid aspirate 
obtained by string capsules can be as sensitive as culture of bone marrow 
aspirates. 
CULTURE 
Conventional blood culture makes the use of BHI broth or bile 
broth or biphasic media for recovery of S,typhi.For the optimum yield of 
the S.Typhi the quantity of blood to culture broth should be 1:10.This will 
dilute the antibacterial substances that are present in the blood38. 
 Conventional blood culture bottles are incubated at 37°C 
aerobically. The tubes are examined daily for the growth (hemolysis, 
turbidity) during first 6 – 18 hours. Serial blind subcultures from BHI 
broth has to be done on Chocolate agar & Mac Conkey agar plates on 
alternative days till 7 days. The growth if any is identified by biochemical 
reactions and confirmed. 
Clot culture 
 Clot is inoculated is inoculated into a broth medium contain 
streptokinase. This method increase the yield of culture positivity. 
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Buffy coat culture  
 About 5 ml of blood mixed with heparin , centrifuged. Then the 
buffy coat can be aspirated and inoculated into solid media straightly or 
after lysis with 0.1% digitonin. This process will be 100% sensitive and 
specific39.  
BONE MARROW CULTURE 
 This is the only bacterial infection of humans for which bone 
marrow aspiration is suggested customarily with sensitivity of more than 
ninety percent. High colony counts are there in the bone marrow when 
comparing to blood and unlike blood culture, are not affected by up to 5 
days of prior antibiotic treatment. 
BILE CULTURE 
 Bile is a suitable culture medium for S.typhi, so helpful to detect 
carrier state. 
STOOL CULTURE 
 S.Typhi are excreted in stool all over the course of illness and even 
during convalescence. It is helpful to detect the carrier state. The 
organism can be isolated from the stools between the third and fifth week 
of the disease39. 
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 Stool culture can be done on plates of one or more types of 
selective media, both directly and after preliminary culture on a liquid 
enrichment medium. The most commonly used media were Selenite F 
broth, DCA, McConkey agar, XLD agar. Wilson and Blair’s medium is 
also a suitable selective medium. When comparing to adults, children 
have increased incidence (sixty percent versus thirty percent) of stool 
culture positivity. 
SEROLOGICAL TESTS 
ANTIBODY DETECTION 
WIDAL TEST 
This test detects agglutinating antibodies to O and H antigens of S. 
Typhi and H antigens of S. Paratyphi A and B. This test becomes positive 
towards the end of the first week and reaches the highest point during the 
third week of illness. Antibody to O antigen are mainly Ig M type and 
increases in the beginning of disease. It disappears quickly. H antigens 
are flagellar antigens of the organism. Generally antibodies to O antigen 
appears on the day six to eight and antibodies to H antigen appears on 
days ten to twelve following the onset of the illness. This tests can be 
done in tubes or on slides38.  
42 
 
The positive Widal test result means demonstration of rising titres 
of antibodies in paired sera taken at ten to fourteen days interval. 
Demonstration of rising antibody titres in a paired sera at on interval of 
seven days is diagnostic of the disease but is too late for taking clinical 
decision making. The test done using a single, acute phase serum sample 
is called as unpaired Widal test, it has lower sensitivity and specificity in 
countries were the enteric fever is endemic. The test results must be 
interpreted with caution in case of previous infection or immunization 
with typoid fever vaccine. The result may be affected due to cross 
reacting epitopes shared with other Enterobacteriaceae, that are present in 
the sample.  
MODIFIED WIDAL TEST 
This test helps to distinguish the recent infection from a past one. A 
positive Widal test may be due to Ig M or Ig G antibodies. In modified 
Widal test, the serum is mixed with 2-mercapto ethanol which can 
selectively inactivate the IgM and leads to decrease in the titres of Widal 
test. The decline in the titres of modified Widal test in contrast to 
customary Widal test points toward latest infection. 
TYPHIDOT ASSAY 
This is a dot-blot enzyme-linked immunosorbant assay which can 
detect specific IgM and IgG antibodies to a 50 kDa Outer Membrane 
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Protein of S. Typhi7. The test uses peroxidase labeled anti-IgM 
(Typhidot-IgM) or anti-IgG antibodies. The detection of IgM antibodies 
indicates the early phase of illness, whereas the detection of both IgG and 
IgM implies acute typhoid in the middle phase of infection3.  
Diagnostic usefulness of the Typhidot test was augmented by 
discriminatory recognition of IgM antibodies. The modified test 
Typhidot-M, which allows inactivation of IgG permits the contact of the 
antigen to the specific IgM. The test is easy, quick, ninety five percent 
sensitive, seventy five percent specific and has high negative and positive 
predictive values. In a study carried out in Vellore, the Typhidot test 
conferred a sensitivity of hundred percent and specificity of eighty per 
cent. 
IGM DIPSTICK TEST 
The typhoid IgM dipstick assay deects of S.Typhi-specific IgM 
antibodies in serum or whole blood samples3. 
ANTIGEN DETECTION 
Rapid latex agglutination- Detects specific antigens in culture 
supernatants. The method is highly sensitive and specific almost 
paralleling blood culture. 
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Co- agglutination test : It is a slide agglutination method uses killed 
Staphylococci (Cowan I strain) having protein A which binds with Fc 
fragment of IgG specific against somatic O antigen of S.enteritidis. This 
test is positive in 1st week of fever with a sensitivity of 86 % and 
specificity of 88 %. It will give negative result after the first week of the 
disease39.  
MOLECULAR METHODS 
DNA probe: DNA probes specific to Vi antigen gene of S. typhi 
has been used for the diagnosis of organism from blood of patients with 
typhoid fever13. This can be done by concentrating the organisms either 
by lysis centrifugation system or by nylon filters to increase the 
sensitivity of the probe. The method is not as much of sensitive when 
compared to blood culture.  
Polymerase chain reaction: PCR based test for detection of S.Typhi 
in the blood samples using flagellin gene has been tried. Two pairs of 
oligonucleotide primers, of which one is nested in the other, are used: 
Highly specific primers ST 1 and ST 2 are used in the first round of the 
PCR to amplify a 458 bp fragment. Nested PCR is highly specific. It can 
detect a bacterial load of 106 organisms. It is a useful test for early 
diagnosis of disease but test is not yet commercially available and 
difficult in areas where typhoid is endemic. 
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OTHER LABORATORY TESTS 
 Leukocytosis is seen in children and within the first 10 days of 
fever. Severe anaemia is unusual and may suggest complications. ESR is 
raised. Mild hyponatremia and Hypokalemia is common. 
Diagnosis of Typhoid carriers 
It is helpful to screen the food handling workers and cooks to 
identify carrier state. Carrier state can be determined by isolating the S. 
typhi in stool, bile or urine. The occurrence and amount of bacillary 
shedding varies and it is necessary, to test repetitive samples. For chronic 
carriers stool is preferred sample38. Diagnosis of urinary carriers requires 
repeated urine cultures. 
 Demonstration of Vi antigens is used as a screening test for carrier 
state. The test was found to be seventy percent sensitive. Other tests that 
can be used to distinguish carrier state were passive heamagglutination 
test, solid phase radioimmunoassay, CIE and ELISA. Carrier tracing in 
cities can be done by ‘Sewer swab technique’.  
DRUG RESISTANCE 
CHLORAMPHENICOL AND TYPHOID 
Chloramphenicol, was introduced for the therapy of typhoid fever 
around 1948 and was the ‘gold standard’ therapy since then. 
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MECHANISM OF ACTION 
Chloramphenicol, was prepared from Streptomyces venezuelae in 
1947. It is bacteriostatic but may be bactericidal in high concentrations. It 
has a wide spectrum of activity against gram-positive and gram-negative 
bacteria and binds to the 50S subunit of bacterial ribosomes, that inhibit 
peptide chain elongation43.  
RESISTANCE TO CHLORAMPHENICOL 
Untill the 1972 it was the undoubted antibiotic for therapy of 
typhoid fever and lead to a decrease in mortality from 10% to < 2%. In 
1950, Anderson et al first to report resistance to Chloramphenicol in 
S.Typhi isolates from England. The first epidemic of Chloramphenicol- 
resistant strain was observed in Mexico in 1972. Resistance to was 
encoded by a plasmid of the inc H 1 incompatibility group now termed 
incHI1 often in combination with resistance to streptomycin, 
sulfonamides, and Tetracyclines. (Rtype-CSSuT).  
Resistance mechanisms to Chlormphenicol include enzyme 
inactivation by acetylation of the drug through Chloramphenicol 
acetyltransferases (CATs). These are encoded by the genes catA1,catA2, 
catB2 that have been demonstrated. Other mechanisms include 
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inactivation by phosphotransferases, efflux systems and mutation at target 
sites and loss of OMP. 
MULTI DRUG RESISTANCE 
With emergence of Chloramphenicol resistant S.Typhi and 
paratyphi A all over world, the focus shifted to other alternatives such as 
Ampicilllin, Co- trimoxable and Tetracycline. There was a good response 
to these drugs until resistace developed. 
Multidrug resistance is defined as resistance to all the three first-
line antibiotics -Ampicillin, Co-trimoxazole and Chloramphenicol16. 
MECHANISM OF ACTION 
Trimethoprim inhibits the enzyme dihydrofolate reductase (DHFR) 
by binding to it’s active site44. DHFR catalyses the reduction of DHFA to 
it’s coenzyme tetrahydrofolate. Sulphonamide with it’s structural analogy 
to paraminobenzoic acid inhibits the enzyme DHPS (dihydropteroate 
synthase) both of which are involved in folate synthesis required for 
thiamine production and bacterial growth. 
AMPICILLIN 
They inhibit bacterial replication by blocking the transpeptidation 
reaction of bacterial cell wall synthesis44. 
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MECHANISMS OF RESISTANCE  
Low level resistance to Trimethoprim is due to drug resistant 
variants of the chromosomal fol A gene encoding the bacterial DHFR. 
High level resistance is attained by bypass mechanism through genes that 
are plasmid mediated and consists of dfrA1, dfrA3, dfrA10 and dfrB6. 
Sulphonamide resistance is by mutations in the gene fol P that encodes 
for DHPS. Acquired resistance is by plasmid mediated genes such as sul 
1 and sul2.  
Resistance to Ampicillin is by production of β- lactamase enzymes 
that hydrolyze the β-lactam ring and sometimes by weakened penetration 
of drug to target PBPs (penicillin binding proteins) in the bacteria. 
FLOUROQUINOLONES 
The drug for MDR came with the discovery of Nalidixic acid, the 
prototype of the quinolones in 1962 during the purification of 
Chloroquine, a quinolone derivative.  
MECHANISM OF ACTION 
The main targets of flouroquinolones are bacterial enzymes DNA 
gyrase and DNA topoisomerse IV with 2 pairs of subunits. DNA gyrase 
is responsible for introducing negative super coiling in the DNA and for 
relieving topological stress during replication44. 
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Quinolones attaches themselves to DNA gyrase or topoisomerase 
IV and induce a conformational alterations in the enzyme leading to the 
break the DNA and prevents relegation by producing a quinolone-DNA-
enzyme complex. 
MECHANISM OF RESISTANCE 
Resistance to FQs is by two mechanisms, target mediated and non 
target mediated. Changesin the target enzymes, DNA gyrase and 
topoisomerseIV is the main mechanism of resistance. Other non target 
mechanisms include reduced accumulation either by efflux or by reduced 
uptake of drug, and plasmid mediated quinolone resistance18. 
Quinolone resistance in Salmonella is related with mutations in 
DNA gyrase mainly in the QRDR region of the A subunit. Plasmid 
mediated resistance genes of qnr (qnr A, qnr B, qnr S, and qnr D ) and 
qnr S1 have been described.  
NARST AND CIPROFLOXACIN 
A few years after the introduction of fluoroquinolones , treatment 
failure was observed with ciprofloxacin. They were termed as NARST18. 
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TREATMENT 
TABLE 3 : TREATMENT OF TYPHOID FEVER3 
  Optimal therapy     Alternative effective drugs 
Susceptibility 
Antibiotic Daily  
dose 
(mg/kg/d
ay 
Days Antibiotic Daily  
dose 
(mg/kg/d
ay 
Days  
Uncomplicated Typhoid Fever 
Fully 
sensitive 
Chloramphenic
ol 
50-75 14-
21 
Fluoroquinolo
ne, 
e.g. ofloxacin 
or  
ciprofloxacin 
15 5-7 
Amoxycillin 75-100 14       
Multidrug-  
resistant 
Flurosquinol 
one 
15 5-7 Azithromycin 20 7 
or           
Cefixime 15-20 7-14 Cefixime 15-20 7-14 
Quinolone- 
resistant 
Azithromycin 10-20 7 Cefixime     
or           
Ceftriaxone 75 10-
17 
  20 7-14 
Severe typhoid fever 
Fully 
sensitive 
Ampicillin 100 14 Fluoroquinolo
ne, 
e.g. ofloxacin 
or  
ciprofloxacin 
15 10-14 
or           
Ceftriaxone 60-75 10-
14 
      
Multidrug-  
resistant 
Fluoroquinolo
ne 
15 10-
14 
Ceftriaxone 60 10-14 
      or     
      Cefotaxime 80 10-14 
Quinolone- 
resistant 
Ceftriaxone 60-75 10-
14 
Azithromycin 20 7 
      Gatifloxacin 10 7 
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TREATMENT OF CARRIERS41 
Carriers of S. Typhi should be decolonized to decrease the risk to 
close contacts . Carriers  who have a normal gallbladder can be treated 
with high-dose intravenous ampicillin, oral ampicillin, or amoxicillin 
combined with probenecid for 6 weeks or, when a multiresistant 
organism is present, with a fluoroquinolone, such as norfloxacin or 
ciprofloxacin. Chronic carriers who cannot be decolonized are treated 
with cholecystectomy if cholelithiasis or cholecystitis is present; such 
patients should receive ampicillin intravenously 7 to 10 days before and 
30 days after cholecystectomy.  
TREATMENT OF RELAPSE41 
The same therapy should be repeated with proper dose and duration 
after sending culture. In case, the empiric antibiotic is not sensitive then it 
should be changed to appropriate sensitive antibiotic and the total 
duration should be based on the antibiotic type. 
PREVENTION 
PUBLIC HEALTH MEASURES40 
Recognition of an increased frequency of human infections with an 
unusual serotype should be followed by an epidemiologic investigation 
aimed at detecting the source and vehicle. Intervention to stop such 
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outbreaks then can be attempted. Careful food processing and storage, 
and proper preparation of foods are helpful in decreasing transmission of 
infection. Appropriate sewage disposal, assurance of a safe water supply 
and adequate cleaning of medical equipment are important public health 
strategies.  
PERSONAL HYGIENIC MEASURES 
Person-to-person spread can be decreased by hand washing after 
defecating or changing diapers, frequent hand washing during preparation 
of foods that might be contaminated (e.g .,meat), and excluding of 
infected individuals from food-handling tasks. 
BREAST- FEEDING 
In the developing world, breast-feeding is key in prevention 
because human milk contains secretory IgA and other factors that protects 
from S.Typhi. 
VACCINATION45 
Vaccines are available against typoid fever.   
Whole cell inactivated typhoid/ paratyphoid vaccines (TA/TAB) 
These were the initial vaccines available. They best suited for 
developing countries as they were effective in children, in expensive, 
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provide immunity for both typhoid and paratyphoid fever. Their enhanced 
reactogenicity led to discontinuation of use. They no longer available. 
ORAL LIVE ATTENUATED TY21A VACCINE 
This contains a live attenuated strain with a mutation of gal E gene 
and devoid of enzyme UDP gal 4 epimerase. It has genetical stability and 
not revert to virulence. It induces local gut immunity. It comes in enteric 
coated preparation as the organism is acid labile. It can be given to 
children 5 years of age and above as the capsules should be swallowed 
intact. 3 doses on alternate days in empty stomach is recommended. 
Antibiotics active against S.Typhi should not be used 3 days before and 3 
days after intake of capsules. Immunity starts within a week after 
completing the course.  
Vi CAPSULAR POLYSACCHARIDE VACCINE 
This contains purified antigenic fraction of Vi capsular 
polysaccharide antigen of bacilli. Each dose having 25 microgram of 
purified polysaccharide in 0.5 ml of phenolic isotonic buffer for i.m or s.c 
use. This vaccine is not immunogenic below 2 years of age. The 
biological marker is anti Vi antibodies and 1 microgram per ml is taken 
as the serological correlate of immunity. This will not interfere with widal 
test results. It is recommended as a single dose in children aged 2 years 
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and above and can be given with all other vaccines. The dose should be 
repeated every three years.  
Vi CONJUGATE TYPHOID VACCINES 
Conjugation of the Vi antigen with a protein carrier would induce a 
T cell dependant immune response. Conjugation of Vi antigen with non 
toxic recombinant Pseudomonas aeruginosa exotoxin A has been 
evaluated in safety, immunogenicity and efficacy trials in Vietnam. Vi 
antigen conjugated with tetanus toxoid has been licensed recently in 
India. It can be given as two doses of 0.5 ml i.m at an interval of 4 to 8 
weeks followed by a booster every ten years. 
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REVIEW OF LITERATURE 
1.  Gosai Mehul et al conducted a study at department of paediatrics, 
B.J Medical college, Ahmedabad during the year 2011. They included a 
150 children with clinical and laboratory diagnosis of typhoid fever in 
their study and observed the variables such as age, sex, clinical features, 
laboratory results and antibiotic sensitivity vivo. Study shown male 
preponderance with male: female ratio of 1.38:1. Vomitting ( 86 %), 
abdominal pain (80 %) and loss of appetite (72%) are 3 frequent 
symptoms at the time of admission, next to fever. They found pallor (66 
%), toxic look (98%), coated tongue (92%), hepatomegaly (53 %) and 
splenomegaly (22 %), icterus (8 %) in their study. The laboratory 
variables noticed are anemia (71 %), leucopenia (18 %), leucocytosis 
(2%), thrombocytopenia (3 %), elevated SGPT (10 %), positive Widal 
test (71%) and positive blood culture (5.33%). The mean defervescence 
period is 6.24 days. The antibiotic sensitivity pattern in vivo is resistance 
to ampicillin (78.12%), amoxycillin (77.5%), cotrimoxazole (84.2%), 
ciprofloxacin(19.5%) and cefotaxime (20%). 
2. Nikhil patankar and Ira sha15 carried out a study to evaluate age 
related clinical and laboratory manifestations of enteric fever in children. 
It was conducted during the year 2007 and at P J Wadia hostpital for 
children, parel, Mumbai. They included all the children with fever with 
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positive Widal test and/or positive blood culture. A retrospective analysis 
of clinical features laboratory parameters and antimicrobial therapy was 
done. A total of thirty three children were included and divided into two 
age groups; < 5year and > 5year. Mean age of presentation was 5±3 
years. Male: Female ratio was 2:1. The observed variables were fever 
(100%), liver enlargement (82%), raised liver enzymes (85%), anemia 
(88%), elevated ESR (80%) and constipation (0%). In the < 5 year age 
group loose stools was common (p=0.05). Thirty percent patients not 
responded to 3rd generation cephalosporins as first line antibiotics. 
Complications noted in 18 % patients. 
3. Ramaswamy ganesh et al8 conducted a retrospective study at 
kanchi kamakodi CHILDS trust hospital, Nungambakkam, Chennai 
during the year 2010. 316 children were included in the study and 59% of 
them were not immunized with typhoid vaccine. They found eosinopenia 
(72%), increased incidence of Nalidixic Acid Recidence Salmonella 
Typhi (p<0.001) and elevated AST, eosinopenia, NARST as predictors of 
severity. The observed variables include vomiting (49%), loose stools 
(29%), liver enlargement (71%), splenomegaly (34%), mild elevation of 
liver enzymes (60%), moderate elevation in liver enzymes (14%) and 
normal liver enzymes (26%). The vaccine efficacy calculated is 32%, was 
calculated by using the formula (incidence among unimmunized – 
incidence among immunized )* 100/ incidence among unimmunized. 
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Complications noted in 4% of patients. They are SIRS (1.3%), hepatitis 
(0.63%), meningitis (0.3%), GI bleed (0.3%) and osteomyelitis(0.3%). 
The logistic regression analysis shown AST and spleen enlargement are 
considerably related to complicated enteric fever. 
4. Jesudason MV and Sivakumar S2 conducted a prospective study at 
Christian Medical College, Vellore during the year 2003. Blood samples 
for blood culture and typhidot test taken from 563 patients. Culture 
positivity noted in 39 patients. Study shown sensitivity (92.3%), 
specificity (98.8%), positive predictive value (85.7%) and negative 
predictive value (99.4%) for typhidot assay. Authors also concluded that 
Typhidot is a rapid, trustworthy and inexpensive investigation for typhoid 
fever and suitable for less equipped institutions.  
5. Zohra begum et al26. and her colleagues done a study at 
mymensingh medical college, Bangladesh in the year 2006 to find out the 
reliability of Typhidot assay. They had taken 100 blood samples out of 
which 14 were positive blood culture method and 73 were positive in 
Typhidot (IgM) assay. The observations were the sensitivity (92.85%), 
specificity (90%), positive predictive value (76.47%), and negative 
predictive value (97.29%) for Typhidot assay. The study also included 20 
febrile controls and 20 healthy normal controls. The Typhidot assay 
shown 20 percent false positive results in non typhoidal febrile group. But 
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false positive rate in healthy normal controls is 0%. This results indicates 
Typhidot assay may be a useful substitute for blood culture in endemic 
countries, where less facilities are available to do a blood culture. This is 
because of high sensitivity, specificity and negative predictive value of 
Typhidot assay. 
6. During the year 2002, Jesudason M et al2. at Christian Medical 
College, Vellore conducted a study to estimate the efficacy of the 
Typhidot assay. Typhidot assay was done on 30 Widal positive sera, 30 
sera from blood culture positive patients, 60 Widal negative sera and 30 
sera from patients whom blood culture grew gram negative vacilli. The 
Typhidot assay had a sensitivity of 100% and specificity of 80% when 
bacteraemic patients were tested. The Typhidot assay was positive for 
both IgG and IgM in 39 sera, IgM alone in 24 sera and IgG alone in 2 
sera. 
7. Sonja J.Olsen et al20. evaluated 3 immunological rapid diagnostic 
methods namely multi test Dip-S-Ticks, Typhidot and TUBEX at two 
hospitals in Vietnam. The sensitivity and specificity finding were as 
follows; 89% and 53% for multi test Dip-S-Ticks , 79% and 89% for 
Typhidot 78% and 89% for TUBEX and 64% and76% for Widal test. 
8.  In a study of isolates from throughout the India during January 
1990- August 1992. 65 percent of S. Typhi were found to be multidrug 
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resistant (MDR). The maximum number of MDR isolates was seen in 
central India (71%) whereas it was least in south (55%). 
9. Between 1989-91, in a report by Jesudason MV et al2, 11% of the 
S.Typhi isolates at Vellore Tamil Nadu were MDR. In another study by 
Padma Krishnan in Chennai, during 2007, 12% of S.Typhi isolates were 
found to be MDR out of a total of 50 isolates showing a significant 
decline. 
10. An outbreak of typhoid due to multi-drug resistant S. Typhi was 
reported from Pondicherry, in south India by R. Sambasive Rao et al. the 
average prevalence of drug resistant strains in 1980-1988 had been 
11.7%, which increased to 52% in 1989-1990. The majority of strains (80 
%) were resistant to Choramphenicol, streptomycin, tetracycline and 
Ampicillin; 40% were resistant to Co-trimoxazole. Resistance was 
plasmid mediated and the strains belonged to Vi phage type O, biotype II. 
In 1996, Harish et al reported 33% MDR isolates of S.Typhi. Madhulika 
et al in 2003 reported 39 % of MDRST from Pondicherry. 
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AIMS AND OBJECTIVES OF THE STUDY 
 To compare the reliability of typhidot assay and Widal test with 
gold standard blood culture method 
 To study about clinical profile of typhoid fever in paediatric age 
group 
 To study about antibiotic sensitivity pattern for enteric fever 
 To study about response to treatment in enteric fever 
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STUDY JUSTIFICATION 
* The emergence of multi drug resistance in S. Typhi to first line 
antibiotics such as ampicillin, chloramphenicol and cotrimoxazole has 
been a concern18. 
* The problem only worsened with the advent of NARST (Nalidixic 
acid resistant s.typhi) making ciprofloxacin a doubtful drug of choice 
for the treatment of enteric fever18. 
* With the changing patterns in antibiogram it is necessary to 
continually monitor the drug resistance pattern and understand the 
mechanisms involved, so that appropriate strategies can be adopted in 
the management of typhoid fever. 
* During the 1st week of fever typhoid fever not easily differentiated 
from malaria, dengue fever, ricketsiosis and leptospirosis. The 
diagnosis of typhoid fever with gold standard blood culture method 
takes about minimum of 5-7 days. 
* This study about the rapid serological diagnosis of typhoid fever by 
typhidot helps in ruling in or ruling out of the disease quickly so 
treatment of the typhoid fever can be initiated early without delay. 
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* It thus can help in preventing the morbidity, mortality associated with 
typhoid fever in children by initiating early intervention. There is 
regional difference in genomic structure and plasticity of the outer 
membrane protein of salmonella typhi, which is tested in typhidot 
assay. 
Very few studies were done about typhidot assay in our part of country. 
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METHODOLOGY  (MATERIALS AND METHODS) 
* Study design – Prospective descriptive study  
* Study place – Institute of Child Health and Hospital for Children, 
Egmore, Chennai 
* Study period –April 2014 to November 2014 
* Study population –children aged 3-12 years  
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INCLUSION AND EXCLUSION CRITERIA 
• Inclusion criteria  
• Fever for ≥ 3 days without obvious focus of infection  
• Abdominal pain , constipation or diarrhoea 
• Coated tongue , toxic look 
• Hepatomegaly, splenomegaly 
• Relative bradycardia, rose spots  
• Exclusion criteria  
• Children immunized with typhoid vaccine  
• Children suffering from fever other than typhoid  
• Children with documented typhoid fever within past 8 weeks  
Sample Size 
   150 
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MANOEUVRE 
* All children enrolled were subjected to detailed history and clinical 
examination. The following tests were done on the day of 
admission. 
* CBC 
* Peripheral smear 
* Chest x ray 
* Urine R/E and culture , sensitivity 
* Liver function test 
* Mantoux test 
* Blood widal test 
* Typhidot M assay 
* Blood culture in brain heart infusion broth 
* Empirical treatment with ceftriaxone will be started, if clinical 
improvement does not occur antibiotic will be changed according 
to antibiogram. 
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* Enrolled children were in follow up for defervesence of fever , 
complications, response to treatment ,hospital stay, alternative 
diagnoses if reached. 
* At the end, descriptive analysis was done. 
* Chi square test done for sensitivity, specificity, positive predictive 
value, negative predictive value for Widal test and Typhidot assay 
with comparing to gold standard blood culture method. 
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OBSERVATIONS & RESULTS 
1. SEX DISTRIBUTION 
A total of 167 children enrolled in the study. It includes 94 male and 73 
female children. 
TABLE 4  
SEX 
Sl.No. Valid Frequency Percent 
1 Male 94 56.3 
2 Female 73 43.7 
3 Total 167 100 
 
CHART 1 
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CHART 2 
 
Out of 167 children 67 (40%) were in the 3-5year age group, 64 
(38%) were in the 6-8 year age group, 36 (22%) were in the 9-12 year age 
group. 
The whole study population can be divided in to three groups.They 
are non typhoidal illness, confirmed case of typhoid fever, probable case 
of typhoid fever. 
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CASE DEFINITION 
NON TYPHOIDAL ILLNESS 
 115 (68.86%) children had other diagnoses like URI, Malaria, 
Acute viral fever, leptospirosis, Acute viral hepatitis and various other 
diagnoses and excluded from the study. 
CONFIRMED CASE OF TYPHOID FEVER 
Children with fever (380 C and above) for at least 3 days, and a 
positive blood culture. In this study 26 (15.56%) confirmed cases were 
present. 
PROBABLE CASE OF TYPHOID FEVER 
A children with fever (380 C and above) for atleast 3 days, with 
positive widal test result but negative result in blood culture method. In 
this study 52 (31.13%) probable cases were present. 
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BLOOD CULTURE POSITIVE CASES 
Out of 167 children, 26 (15.6%) children had S.Typhi grown in 
blood culture method.They are culture positive and confirmed cases of 
typhoid fever, since blood culture method is considered as gold standard 
method for diagnosing typhoid fever. 
TABLE 5  
BLOOD CULTURE POSITIVITY 
Sl.No. Valid Frequency Percent 
1 Positive 26 15.6 
2 Negative 141 84.4 
3 Total 167 100 
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 Clinical features of this 15.6% patients will be described in 
following pages. 
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FEVER 
 All the 26 children had fever. Temperature profile at the time of 
admission is shown in the following table. 
TABLE 6 
TEMP. AT ADMISSION 
Sl.No. Valid Frequency Percent 
1 99-1000 F 7 26.9 
2 100-1010 F 4 15.4 
3 101-1020 F 6 23.1 
4 102-1030 F 5 19.2 
5 103-1040 F 3 11.5 
6 > 1040 F 1 3.8 
7 TOTAL 26 100 
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CHILLS 
61.5% confirmed cases had chills. 
TABLE 7 
CHILLS 
Sl.No. Valid Frequency Percent 
1 Present 16 61.5 
2 Absent 10 38.5 
3 Total 26 100 
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CONSTIPATION 
Out of 26, only one child had constipation (3.8%). 
TABLE 8 
CONSTIPATION 
Sl.No. Valid Frequency Percent 
1 Present 1 3.8 
2 Absent 25 96.2 
3 Total 26 100 
 
DIARRHOEA 
Out of 26, only 9 children had diarrhoea (34.6%). 
TABLE 9 
DIARRHOEA 
Sl.No. Valid Frequency Percent 
1 Present 9 34.6 
2 Absent 17 65.4 
3 Total 26 100 
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VOMITING 
65.4% children had vomiting. 
TABLE 10 
VOMITING 
Sl.No. Valid Frequency Percent 
1 Present 17 65.4 
2 Absent 9 34.6 
3 Total 26 100 
 
CHART 7 
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ABDOMINAL PAIN 
12 children out of 26 had abdominal pain (46.2%). 
TABLE 11 
ABDOMINAL PAIN 
Sl.No. Valid Frequency Percent 
1 Present 12 46.2 
2 Absent 14 53.8 
3 Total 26 100 
 
ABDOMINAL DISTENSION 
Only 3 out of 26 had abdominal distension (11.5%). 
TABLE 12 
ABDOMINAL DISTENSION 
Sl.No. Valid Frequency Percent 
1 Present 3 11.5 
2 Absent 23 88.5 
3 Total 26 100 
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COUGH 
57.7% patient had cough. 
TABLE 13 
COUGH 
Sl.No. Valid Frequency Percent 
1 Present 15 57.7 
2 Absent 11 42.3 
3 Total 26 100 
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ANOREXIA 
Out of 26, 17 patient had anorexia. 
TABLE  14 
ANOREXIA 
Sl.No. Valid Frequency Percent 
1 Present 15 57.7 
2 Absent 11 42.3 
3 Total 26 100 
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JOINTPAIN 
Only 7 chidren out of 26 children, had joint pain. 
TABLE 15 
JOINTPAIN 
Sl.No. Valid Frequency Percent 
1 Present 7 26.9 
2 Absent 19 73.1 
3 Total 26 100 
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EPISTAXIS 
Only one child had epistaxis (3.8%). 
TABLE 16 
                                EPISTAXIS 
Sl.No. Valid Frequency Percent 
1 Present 1 3.8 
2 Absent 25 96.2 
3 Total 26 100 
 
HEADACHE 
42.3% of patients had headache. 
TABLE 17 
                                          HEADACHE 
Sl.No. Valid Frequency Percent 
1 Present 11 42.3 
2 Absent 15 57.7 
3 Total 26 100 
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ALTERED MENTAL STATUS 
Only one child had altered mental status. 
TABLE 18 
ALTERED MENTAL STATUS 
Sl.No. Valid Frequency Percent 
1 Present 1 3.8 
2 Absent 25 96.2 
3 Total 26 100 
 
SEIZURES AND LOSS OF CONSCIOUSNESS 
None of the patient had seizures or loss of consciousness. 
HISTORY OF CONTACT WITH TYPHOID FEVER PATIENT 
One one child had history of contact with typhoid fever patient. 
CLINICAL FEATURES 
PALLOR 
5 children out of 26 children had clinical pallor. 
JAUNDICE 
Non of the patient had clinically detectable icterus. 
EDEMA 
None of the child had edema. 
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LYMPHADENOPATHY 
26.9% children had lymphadenopathy. 
TABLE 19 
LYMPHADENOPATHY 
Sl.No. Valid Frequency Percent 
1 Present 7 26.9 
2 Absent 19 73.1 
3 Total 26 100 
 
CHART 11 
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TOXIC LOOK 
76.9% patients had toxic look. 
                                               TABLE 20 
TOXIC LOOK 
Sl.No. Valid Frequency Percent 
1 Present 20 76.9 
2 Absent 6 23.1 
3 Total 26 100 
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ROSE SPOTS 
None of the patients had rose spots. 
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COATED TONGUE 
Coated tongue noted in 73.1% of patients. 
                                             TABLE 21 
COATED TONGUE 
Sl.No. Valid Frequency Percent 
1 Present 19 73.1 
2 Absent 7 26.9 
3 Total 26 100 
 
CHART 13 
 
 
  
19
7
COATED TONGUE
Present
Absent
84 
 
ABDOMINAL TENDERNESS 
10 (38.5%) patients out of 26 patients had abdominal tenderness. 
TABLE 22 
ABDOMINAL TENDERNESS 
Sl.No. Valid Frequency Percent 
1 Present 10 38.5 
2 Absent 16 61.5 
3 Total 26 100 
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HEPATOMEGALY 
Hepatomegaly is noted in 61.5% patients. 
TABLE 23 
HEPATOMEGALY 
Sl.No. Valid Frequency Percent 
1 Present 16 61.5 
2 Absent 10 38.5 
3 Total 26 100 
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SPLENOMEGALY 
12 (46.2%) patients out of 26 blood culture positive patients had 
splenomegaly. 
TABLE 24 
SPLENOMEGALY 
Sl.No. Valid Frequency Percent 
1 Present 12 46.2 
2 Absent 14 53.8 
3 Total 26 100 
 
CHART 16 
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Out of 26 culture positive patients 38% (10) had both liver and 
spleen enlargement.  
LUNG SIGNS 
Lung signs (bronchial breath sounds, crackles, wheeze, tracheal 
deviation, etc.) are noted only in 2 (7.7%) patients.One child had wheeze, 
another had bilateral crepitations. 
MURMER 
Cardiac murmer noted in 2 patients (7.7%). but they were innocent 
murmers. 
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LABORATORY PARAMETERS 
HEMOGLOBIN LESS THAN 10 mg/dl 
53.8% patients had hemoglobin value less than 10 mg/dl. 
TABLE 25 
HEMOGLOBIN LESS THAN 10 mg/dl 
Sl.No. Valid Frequency Percent 
1 Present 14 53.8 
2 Absent 12 46.2 
3 Total 26 100 
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LEUCOPENIA 
11.5% patients had leucopenia. 
                                                  TABLE 26 
LEUCOPENIA 
Sl.No. Valid Frequency Percent 
1 Present 3 11.5 
2 Absent 23 88.5 
3 Total 26 100 
 
TOTAL WBC COUNT BETWEEN 4000 TO 10000. 
This normal leucocyte count is noted in 46.2 % patients.          
TABLE 27 
TOTAL WBC COUNT BETWEEN 4000 TO 10000. 
Sl.No. Valid Frequency Percent 
1 Present 12 46.2 
2 Absent 14 53.8 
3 Total 26 100 
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LEUCOCYTOSIS 
Total WBC count more than 10000 is noted in 42.3 % patients. 
                                                TABLE 28 
LEUCOCYTOSIS 
Sl.No. Valid Frequency Percent 
1 Present 11 42.3 
2 Absent 15 57.7 
3 Total 26 100 
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THROMBOCYTOPENIA 
Platelet count less than 100000 noted in only one patient. 
                                             TABLE 29 
THROMBOCYTOPENIA 
Sl.No. Valid Frequency Percent 
1 Present 1 3.8 
2 Absent 25 96.2 
3 Total 26 100 
URINE ALBUMIN AND URINE SUGAR 
None of the patient in blood culture positive group showed urine 
albumin and urine sugar detection on urine routine examination. 
URINE CULTURE AND SENSITIVITY 
Only one patient had pathogenic bacterial growth in urine culture. 
He had associated urinary tract infection with E. coli. 
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PERIPHERAL SMEAR FOR MALARIAL PARASITE 
None of the patient in blood culture positive for S.typhi group had 
malarial parasite in their peripheral smear. 
CHEST X RAY 
2 children out of 26 children had abnormal findings chest x ray. 
One had bilateral hyper ventilation, another one had pneumonitis patch in 
Right lower lobe. 
SERUM BILIRUBIN LEVEL 
None of the patient had elevated serum bilirubin level. 
SERUM SGOT LEVEL  
8 patients out of 26 had elevated serum SGOT level (30.8%).Out f 
this 8 patients 6 patients had mild elevation and 2 had moderate elevation 
in serum SGOT level.But none of the patient had marked elevation in 
serum SGOT level. 
                                   TABLE 30 
SERUM SGOT LEVEL 
Sl.No. Valid Frequency Percent 
1 Elevated 8 30.8 
2 Not elevated 18 69.2 
3 Total 26 100 
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SERUM SGPT LEVEL 
10 patients out of 26 (38.5%) patients had elevated serum SGPT levels. 
Out of this 10 patients, 7 patients had mild elevation and 3 patients had 
marked elevation. 
TABLE 31 
SERUM SGPT LEVEL 
Sl.No. Valid Frequency Percent 
1 Elevated 10 38.5 
2 Not elevated 16 61.5 
3 Total 26 100 
CHART 20 
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21
5
WIDAL TEST POSITIVITY
Positive
Negative
MANTOUX TEST 
None of the patient in 26 patients had positive Mantoux test. 
WIDAL TEST 
21 patient out of 26 patients had positive widal test. This 
corresponds to 80.8% positivity in blood culture positive group. 
TABLE 32 
WIDAL TEST POSITIVITY 
Sl.No. Valid Frequency Percent 
1 Positive 21 80.8 
2 Negative 5 19.2 
3 Total 26 100 
CHART 21 
Titre O level is elevated upto 160 units in 13 patients 
Titre O level is elevated upto 320 units in 8 patients. 
Titre H level is elevated upto 160 units in 12 patients. 
Titre H level is elevated upto 320 units in 8 patients. 
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23
3
TYPHIDOT ASSAY POSITIVITY
Positive
Negative
TYPHIDOT ASSAY 
23 patients had positive typhidot assay, 3 patients had negative 
typhidot assay. 
This corresponds to 88.5% positivity. 
TABLE 33 
TYPHIDOT ASSAY POSITIVITY 
Sl.No. Valid Frequency Percent 
1 Positive 23 88.5 
2 Negative 3 11.5 
3 Total 26 100 
 
CHART 22 
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ANTIBIOTIC SENSITIVITY PATTERN 
AMPICILLIN 
10 blood cultures (38.5%) were sensitive to ampicillin. 
1 blood culture (3.8%) had moderate sensitivity. 
15 blood cultures (57.7%) were not sensitive to ampicillin. 
TABLE 34 
AMPICILLIN 
 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 10 38.5 
2 RESISTANT 15 57.7 
3 MODERATELY SENSITIVE 1 3.8 
4 Total 26 100.0 
 
CHART 23 
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AMIKACIN 
12 blood cultures (46.2%) were sensitive to amikacin sulphate. 
14 blood cultures (53.8%) were resistant to amikacin sulphate. 
TABLE 35 
AMIKACIN 
 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 12 46.2 
2 RESISTANT 14 53.8 
3 Total 26 100.0 
 
CHART 24 
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CIPROFLOXACIN 
17 isolates (65.4%) were sensitive to ciprofloxacin. 
1 isolate (3.8%) had moderate sensitivity to ciprofloxacin. 
8 isolates (30.8%) were not sensitive to ciprofloxacin. 
TABLE 36 
CIPROFLOXACIN 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 17 46.2 
2 RESISTANT 8 53.8 
3 MODERATELY SENSITIVE 1 3.8 
4 Total 26 100.0 
 
CHART 25 
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CEFOTAXIM 
20 isolates (76.9%) were sensitive to cefotaxim. 
1 isolate (3.8%) had moderate sensitivity. 
5 isolates (19.2%) were resistant to cefotaxim. 
TABLE 37 
CEFOTAXIM 
 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 20 76.9 
2 RESISTANT 5 19.2 
3 MODERATELY SENSITIVE 1 3.8 
4 Total 26 100.0 
 
CHART 26 
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CEFTRIAXONE 
24 isolates (92.3%) out of 26 isolates were sensitive to ceftriaxone. 
Only 2 isolates (7.7%) were resistant to ceftriaxone. 
TABLE 38 
CEFTRIAXONE 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 24 92.3 
2 RESISTANT 2 7.7 
 Total 26 100.0 
 
CHART 27 
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CHLORAMPHENICOL 
14 isolates (53.8%) were sensitive to chloramphenicol. 
2 isolates (38.5%) were moderately sensitive to chloramphenicol. 
10 isolates (38.5%) were resistant to chloramphenicol. 
TABLE 39 
CHLORAMPHENICOL 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 14 53.8 
2 RESISTANT 10 38.5 
3 MODERATELY SENSITIVE 2 7.7 
4 Total 26 100.0 
 
CHART 28 
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NALIDIXIC ACID 
4 isolates (15.4%) were sensitive to nalidixic acid. 
2 isolates (7.7%) were moderately sensitive to nalidixic acid. 
20 isolates (76.9%) were resistant to nalidixic acid. 
TABLE 40 
NALIDIXIC ACID 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 4 15.4 
2 RESISTANT 20 76.9 
3 MODERATELY SENSITIVE 2 7.7 
4 Total 26 100.0 
 
CHART 29 
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COTRIMOXAZOLE 
10 isolates (38.5%) were sensitive to cotrimoxazole. 
1 isolate (3.8%) had moderate sensitivity to cotrimoxazole. 
15 isolates (57.7%) were resistant to cotrimoxazole. 
TABLE 41 
COTRIMOXAZOLE 
Sl.No. Valid Frequency Percent 
1 SENSITIVE 10 38.5 
2 RESISTANT 15 57.7 
3 MODERATELY SENSITIVE 1 3.8 
4 Total 26 100.0 
CHART 30 
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MDR S. 
TYPHI
23%
OTHERS
77%
MDR S.Typhi
MULTIDRUG RESISTANCE 
Isolates resistant to all the three firstline antibiotics viz . ampicillin, 
chloramphenicol, cotrimoxazole are MDR isolates. Incidence of MDR 
isolates in this study is 23%. 
CHART 31 
 
COURSE DURING THE HOSPITAL STAY  
DAY ON WHICH FEVER DEFERVESCENCE OCCURS 
Only one patient had fever defervescence on day 1. 
Three patients had fever defervescence on day 2. 
Four patients had fever defervescence on day 4. 
Five patients had fever defervescence on day 5. 
Five patients had fever defervescence on day 6. 
Six patients had fever defervescence on day 7. 
One patient had fever defervesence onday 8. 
One patient had fever defervescence on day 12. 
Mean value for fever defervescence is 5.28 days. 
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TABLE 42 
FEVER DEFERVESCENSE 
Sl.No. Valid Frequency Percent 
1 2nd day 1 3.8 
2 3rd day 3 11.5 
3 4th day 4 15.4 
4 5th day 5 19.2 
5 6th day 5 19.2 
6 7th day 6 23.1 
8 8th day 1 3.8 
9 > 8 day 1 3.8 
CHART 32 
CHANGES IN THE ORGANOMEGALY 
This parameter is to note either increase or decrease in the size of 
organomegaly. Out of 26 patients only 6 had decrase in the size of 
hepatomegaly. No significant change is noted in 20 patients. No change is 
noted in the size of splenomegaly. 
1 patient had decrease in hepatomegaly by 3rd day. 
2 patient had decrease in hepatomegaly by4th day. 
1 patient had decrease in hepatomegaly by 5th day. 
1 patient had decrease in hepatomegaly by 6th day. 
1 patient had decrease in hepatomegaly by 7th day. 
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CHART 33 
 
 
 
SENSITIVITY, SPECIFICITY, POSITIVE PREDICTIVE VALUE, 
NEGATIVE PREDICTIVE VALUE OF TYPHIDOT ASSAY 
Out of 26 blood culture positive cases which has taken as a gold 
standard was compared with the typhidot assay where 23 showed positive 
results and only 3 cases were negative by typhidot. The remaining 26 (out 
of 49) which were blood culture negative showed positive results with 
typhidot test. Typhidot assay had the sensitivity of 88.46%, specificity of 
81.56%, positive predictive value of 46.94% and negative predictive 
value of 97.46% in comparison with blood culture results.  
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TABLE 43 
CROSSTAB 
COMPARISON OF TYPHIDOT WITH BLOOD CULTURE 
 
ENTERIC CULTURE 
Total 
Positive Negative 
TYPHIDOT 
Positive 23 26 49 
Negative 3 115 118 
Total 26 141 167 
 
CHART 34
 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
140
Blood cul Positve Blood  culture 
negative
Typhidot Positive
Typhidot negative
108 
 
VALUES FOR TYPHIDOT ASSAY 
TABLE 44 
 
TABLE 45 
  
Chi-Square Tests for typhidot assay 
 Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 51.916a 1 .000   
Continuity Correctionb 48.593 1 .000   
Likelihood Ratio 48.738 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
51.605 1 .000   
N of Valid Cases 167     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 7.63. 
b. Computed only for a 2x2 table 
Sensitivity = 88.46 % 95% CI: 69.82 % to 97.42 % 
Specificity = 81.56 % 95% CI: 74.16 % to 87.58 % 
Positive 
Likelihood 
Ratio 
= 4.80 95% CI: 3.30 to 6.97 
Negative 
Likelihood 
Ratio 
= 0.14 95% CI: 0.05 to 0.41 
Disease 
prevalence = 15.57 % (*) 95% CI: 10.43 % to 21.97 % 
Positive 
Predictive 
Value 
= 46.94 % (*) 95% CI: 32.54 % to 61.72 % 
Negative 
Predictive 
Value 
= 97.46 % (*) 95% CI: 92.74 % to 99.44 % 
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TABLE 46 
Symmetric Measures 
 Value Asymp. Std. Errora Approx. T
b Approx. Sig. 
Measure of 
Agreement Kappa .515 .074 7.205 .000 
N of Valid Cases 167    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
SENSITIVITY, SPECIFICITY, POSITIVE PREDICTIVE VALUE, 
NEGATIVE PREDICTIVE VALUE OF WIDAL TEST . 
Out of 26 blood culture positive cases which has taken as gold 
standard was compared with the widal test where only 21 showed 
positive results and 5 were negative. The remaining 31 (out of 52 ) which 
were blood culture negative showed positive results with widal test. 
Widal test has sensitivity of 80.77%, specificity of 78.01%, positive 
predictive value of 40.38% and negative predictive value of 95.65% in 
comparison with blood culture results. 
Cross tab for widal test 
TABLE 47 
 ENTERIC CULTURE Total 
Positive Negative 
WIDAL 
Positive 21 31 52 
Negative 5 110 115 
TOTAL 26 141 167 
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VALUES FOR WIDAL TEST 
TABLE 48 
Sensitivity = 80.77 % 95% CI: 60.64 % to 93.37 % 
Specificity = 78.01 % 95% CI: 70.27 % to 84.54 % 
Positive 
Likelihood 
Ratio 
= 3.67 95% CI: 2.56 to 5.28 
Negative 
Likelihood 
Ratio 
= 0.25 95% CI: 0.11 to 0.54 
Disease 
prevalence = 15.57 % (*) 
95% CI: 10.43 
% to 21.97 % 
Positive 
Predictive 
Value 
= 40.38 % (*) 95% CI: 27.01 % to 54.90 % 
Negative 
Predictive 
Value 
= 95.65 % (*) 95% CI: 90.14 % to 98.56 % 
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TABLE 49 
CHISQUARE TESTS FOR WIDAL TEST 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 35.377a 1 .000   
Continuity Correctionb 32.688 1 .000   
Likelihood Ratio 33.152 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
35.165 1 .000   
N of Valid Cases 167     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 8.10. 
b. Computed only for a 2x2 table 
 
TABLE 50 
Symmetric Measures for widal test 
 Value 
Asymp. Std. 
Errora Approx. Tb Approx. Sig. 
Measure of 
Agreement 
Kappa .418 .075 5.948 .000 
N of Valid Cases 167    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
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TYPHIDOT ASSAY POSITIVITY IN RELATION TO DURATION OF FEVER 
CHART 35 
 
TABLE 51 
 
NO OF DAYS OF FEVER * TYPHIDOT Crosstabulation 
Count 
 
TYPHIDOT 
Total 
positive negative 
NO OF DAYS OF FEVER 
4 2 9 11 
5 3 15 18 
6 5 14 19 
7 7 14 21 
8 6 9 15 
9 5 11 16 
10 4 18 22 
11 4 6 10 
12 3 3 6 
13 3 4 7 
14 2 4 6 
15 2 2 4 
16 1 1 2 
18 0 2 2 
20 2 3 5 
21 0 2 2 
30 0 1 1 
Total 49 118 167 
In this study 34.6% of positive results in typhidot assay obtained 
during first week of fever. 
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DISCUSSION AND SUMMARY 
Though typhoid fever is a common infection in children, it is 
difficult to diagnose because of its nonspecific symptoms and signs. 
However it is necessary to diagnose early to initiate appropriate antibiotic 
therapy because delay in starting antibiotic treatment may lead to several 
morbidities and even death. The gold standard for diagnosing typhoid 
fever has always been the blood culture method. But the results of blood 
culture will be available only after a minimum of 5 days and need well 
equipped laboratory set up with experienced technical personals. It is 
costlier also. This delay may result in complications of typhoid fever. 
Typhidot is one of the rapid diagnostic method available for 
diagnosis of typhoid fever. Its efficacy has been tested in various studies 
all around the world, but only very few studies have been done in our part 
of country. This study was primarily carried out to compare the typhidot 
assay with age old Widal test while taking blood culture as gold standard 
method and also to monitor the antibiotic sensitivity pattern and various 
clinical features of the typhoid fever. 
  
114 
 
AGE GROUP 
The predominant age group in the study population was children 3-
5 years old, accounting for (67) 40% of cases studied. The second 
common age group was children 6-8 years, about (64) 38%, followed by 
children aged 9-12 years about (36) 22%. 
SEX 
There was a total of 94 (56.3%) males and 73 (43.7%) females in 
study population. The male: female ratio in the study group was 1.28: 1, 
having male predominance.13 males (13.8%) and 13 females (17.8%) had 
a positive blood culture.  
TYPHIDOT ASSAY 
The sensitivity of typhidot assay is 88.56 % in this present study, 
which is comparable to most of the other studies. 
Authour 
name/year Sample size Sensitivity (%) Specificity (%) 
K E Choo/1994 149 90% 91% 
Butta ZA et al 
/1999 97 94% 89% 
Jesudasan M et al 
/2002 150 100% 80% 
Narayanappa et 
al /2010 105 92% 38% 
Present study 167 88.46% 81.56% 
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 So, typhidot fulfills one of the standard for an ideal diagnostic test 
as it does not usually miss the diagnosis when compared to blood culture. 
However three blood culture positive cases were had negative results in 
typhidot assay. These three false negative results may be due to covering 
of the Ig M antibody by Ig G antibodies during the second week of fever. 
26 false positive results (out of 49) of typhidot observed. 
Interestingly 20 out of this 26 patients were also positive in widal test 
also. This finding could be attributed to 
1. Endemicity of typhoid fever in the region signifying preexisting 
antibodies from earlier exposure or may be due to subclinical infection. 
2. The patient may have had infection with non typhoidal 
salmonella serotype that share common antigens with S.Typhi.  
Thus it can be considered that, though typhidot provided false 
positive results in 26 cases these patients may actually have had S. Typhi 
infection, either in the past or subclinical, which the blood culture failed 
to detect. 
Analysis of the observations in this study, indicates that although 
blood culture is the gold standard for diagnosis of typhoid fever, typhidot 
assay might be a sensible alternative in the developing countries because 
of its high sensitivity, specificity and negative predictive value. Typhidot 
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will be particularly helpful in those areas where facilities for doing a 
blood culture is not available. 
Furthermore manufacturer of typhidot says that it can become 
positive within 2-3 days of infection .In the present study 34.6% of 
positive results obtained during the first week of fever. Positive results 
seen from 4th day onwards. But widal test will become positive only after 
the first week of fever, because antibodies to O and H antigens are 
produced only after first week. Thus, typhidot assay allows early 
recognition and treatment of typhoid fever. 
Disadvantages of typhidot assay include  
 It is costlier than widal test . 
  It should be stored at 4-80 C. Cold storage is required for 
reagents. 
 It does not give antibiogram. 
WIDAL TEST 
The sensitivity and specificity, negative predictive value of widal 
test in this study were 80.77%, 78.01%, 95.65% respectively. All of them 
lower than that of typhidot in this study. So it is less reliable than the 
typhidot test to diagnose typhoid fever in endemic regions. Further more 
it has the following disadvantages23 
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 It necessitates both acute and convalescent sera 
 More time consuming 
 Intrinsic inconsistencies with the test 
 Difficulty in establishing a steady state baseline titre for the 
population. 
 Recurrent exposures to S.typhi in endemic regions 
 Cross reactivity with other non Salmonella organisms 
 Lack of reproducibility of test results. 
 
Despite all this limitations it is still in use particularly in areas that cannot 
meet the expense of the costlier diagnostic tests. 
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SYMPTOM ANALYSIS 
The presenting symptoms of the 26 blood culture positive, 
confirmed cases of typhoid fever is as follows: 
S.NO SYMPTOM FREQUENCY PERCENTAGE 
1 Fever 26 100% 
2 Chills 16 61.5% 
3 Constipation 1 3.8% 
4 Diarrhoea 9 34.6% 
5 Vomiting 17 65.4% 
6 Abdominal pain 12 46.2% 
7 Abdominal 
distension 
3 11.5% 
8 Cough 15 57.7% 
9 Anorexia 17 65.4% 
10 Joint pain 7 26.9% 
11 Epistaxis 1 3.8% 
12 Head ache 11 42.3% 
13 Altered mental status 
1 3.8% 
14 Seizures 0 0.0% 
 
From the above table we find the most commonest symptoms were 
fever with chills, vomiting, cough and anorexia which was present in 
more than half (50%) of the study population. 
Fever is present in all of the patients. The mean value for duration 
of fever is 9.3 days. 
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CLINICAL SIGNS 
The clinical signs observed in 26 culture positive confirmed cases 
is as follows; 
S.NO SIGNS FREQUENCY PERCENTAGE 
1 Pallor 5 26% 
2 Icterus 0 0% 
3 Lymphadenopathy 7 26.9% 
4 Toxic look 20 76.9% 
5 Rose spots 0 0% 
6 Coated tongue 19 73.1% 
7 Abdominal tenderness 10 38.5% 
8 Hepatomegaly 16 61.5% 
9 Splenomegaly 12 46.2% 
10 Hepatosplenomegaly 10 38.0% 
11 Lung signs 2 7.7% 
 
The most commonly observed clinical signs in this study are toxic 
look, coated tongue, hepatomegaly, splenomegaly. Incidence of 
hepatomegaly ranges from 30-70% in various studies. Incidence of 
splenomegaly ranges from 20-50% in various studies. 
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LABORATORY PARAMETERS 
S.NO LABORATORY PARAMETER FREQUENCY PERCENTAGE 
1 ANEMIA 14 53.8% 
2 LEUCOPENIA 3 11.5% 
3 NORMAL LEUCOCYTE COUNT 12 46.2% 
4 LEUCOCYTOSIS 11 42.3% 
5 THROMBOCYTOPENIA 1 3.8% 
6 URINE ALBUMIN 0 0.0% 
7 URINE SUGAR 0 0.0% 
8 URINE CULTURE 1 3.8% 
9 SMEAR FOR MALARIAL PARASITE 0 0.0% 
10 CHEST X RAY 2 7.7% 
11 HYPERBILIRUBINEMIA 0 0.0% 
12 SGOT ELEVATION 8 30.8% 
13 SGPT ELEVATION 10 38.5% 
14 MANTOUX TEST 0 0.0% 
 
The most commonest laboratory parameters were anemia, normal 
WBC count and liver enzyme elevation. Reported incidence of anemia in 
typhoid fever varies from 30-60%, in various studies. 
Most of the patients had normal leucocyte count in this study, 
which is similar to other studies. 
Elevation of liver enzymes was observed in 38.5% patients, which 
is lower when compared to earlier study by Khosla et al which reported 
hepatic dysfunction in 55% of cases. 
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COMPARISON OF FEATURES IN BLOOD CULTURE POSITIVE 
AND TYPHIDOT POSITIVE GROUPS 
S.NO PARAMETERS 
BLOOD 
CULTURE 
POSITIVE 
GROUP (%) 
TYPHIDOT 
POSITIVE 
GROUP (%) 
1 Cough 57.7% 42.9% 
2 Vomiting 65.4% 69.4% 
3 Abdominal pain 46.2% 53.1% 
4 Diarrhoea 34.6% 36.7% 
5 Abdominal distension 11.5% 12.2% 
6 Anorxia 65.4% 59.2% 
7 Altered mental status 3.8% 4.1% 
8 Lymphadenopathy 26.9% 34.7% 
9 Coated tongue 73.1% 69.4% 
10 Toxic look 76.9% 67.3% 
11 Abdominal tenderness 38.5% 51.0% 
12 Hepatomegaly 61.5% 42.9% 
13 Splenomegaly 46.2% 30.6% 
14 Anemia 53.8% 49.0% 
15 Leucopenia 11.5% 12.2% 
16 Normal WBC count 46.2% 46.9% 
17 Thrombocytopenia 3.8% 4.1% 
18 Urine culture growth 3.8% 16.3% 
19 Malarial parasite in PS 0.0% 8.2% 
20 hyperbilirubinemia 0.0% 12.2% 
21 Liver enzymes elevation 69.2% 73.5% 
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BLOOD CULTURE 
Blood culture positivity in the present study is 15.6%, comparable 
to observations made in Kolkata (21%), bangladesh (14%) and several 
other studies. The comparatively lower sensitivity of blood culture was 
because of prevalent and ridiculous use of antimicrobial agents and also 
difficulties in drawing sufficient amout of blood for cultures in children. 
ANTIBIOTIC SENSITIVITY PATTERN 
S.NO ANTIBIOTIC SENSITIVE 
( %) 
INTERMEDIATE 
(%) 
RESISTANT 
(%) 
1 Ampicillin 38.5% 3.8% 57.7% 
2 Amikacin 46.2% - 53.8% 
3 Ciprofloxacin 65.4% 3.8 30.8% 
4 Cefotaxim 76.9% 3.8% 19.2% 
5 Ceftriaxone 92.3% - 7.7% 
6 Chloramphenicol 53.8% 7.7% 38.5% 
7 Nalidixic acid 15.4% 7.7% 76.9% 
8 Cotrimoxazole 38.5% 3.8% 57.7% 
 
Ceftriaxone, cefotaxim and ciprofloxacin are three antibiotics 
having highest sensitivity in this study. This observation is similar those 
found in study of sherwal et al. 
Incidence of Multi Drug Resistant S. Typhi in this study is 23%.Six 
out of 26 patients had MDR S.typhi. Four out of this six are under 5 years 
of age , 5 had both liver and spleen enlargement and one had 
splenomegaly only. 
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Incidence of Nalidixic Acid Resistant Salmonella Typhi is 76.9% 
and is higher than the resistance found in the study of Ramaswamy 
Ganesh et al. conducted during 2008, in this same Chennai. In his study 
he noted an increase in incidence of NARST from the year 2005 to 2008 
(53% to 73%).Now, in this study it is almost 78%.  
The antibiogram of S. typhi have been going through significant 
alterations over a period of time. Although multidrug resistance looks to 
be tapering at one end, there have been widespread reports of NAR in S. 
typhi and S. paratyphi all around the world that are responsible for 
decreased susceptibility to ciprofloxacin resulting in treatment failures 
and amplified chances of complications when flouroquinolones are used 
for management of typhoid fever. 
RESPONSE TO TREATMENT 
 All the blood culture positive patients responded well to empirical 
ceftriaxone treatment and mean value for fever defervescence is 5.28 
days. 
 46 out of 49 typhidot positive patients responded to empirical 
ceftriaxone and only three of them needed antibiotic change according to 
antibiogram.  
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CO-INFECTIONS 
None of the culture positive patient had malarial parasite in their 
peripheral smear, even though coinfection with malarial parasite is 
common in tropical regions. But 3 patients (6.1%) in typhidot positive 
group had malarial parasite in peripheral smear.  
Only one patient (3.8%) had culture proven urinary tract infection with E. 
coli. Positive mantoux test is not observed in any of the patients. 
COMPLICATIONS 
No mortality is noted in this study. 
Intestinal hemorrhage, osteomyelitis, myocarditis, meningitis, infection 
associated hemophagocytic lymphohistiocytosis are not seen in any of the 
patient. 1 patient (3.8%) admitted with septic shock. 8 patient had 
evidence of typhoid hepatitis. 
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CONCLUSION 
 Symptoms of the typhoid fever in children are non-specific, 
however presence of vomiting, abdominal pain, cough, anorexia 
and diarrhea in febrile child with history of fever more than 3 days 
should prompt the paediatrician to consider the possibility of 
typhoid fever. Likewise presence of toxic look, coated tongue, 
abdominal tenderness, hepatomegaly and splenomegaly in a febrile 
child are suggestive of typhoid fever. 
 The laboratory parameters frequently associated with typhoid fever 
are anemia, normal WBC count and elevated liver enzymes. 
 Typhidot assay is more sensitive, specific, rapid and has more 
predictability of a negative test when comparing to widal test. It 
can be used as a suitable alternative to widal test in regions where 
facilities for culturing the blood is not available to diagnose the 
typhoid fever. 
 It is necessary to monitor the antibiotic sensitivity pattern as it is 
changing frequently over a period of time to avoid improper 
antibiotic usage, treatment failures and allowing the resistance to 
develop. The third generation cephalosporin Ceftriaxone is suitable 
for empirical first line therapy than Ciprofloxacin as there is a 
increasing trend in Nalidixic Acid Resistant Salmonella Typhi 
isolates. 
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LIMITATIONS OF THE STUDY 
Sample size is smaller in this study. If more children were enrolled 
in the study a more detailed picture of clinical features and laboratory 
features could be obtained. Large scale prospective evaluation of typhidot 
assay in endemic popuations should be done to find the exact usefulness 
of typhidot assay. 
FUTURE DIRECTIONS 
Currently the blood culture is the gold standard investigation for 
diagnosing typhoid fever. But obtaining a positive culture is difficult 
because of widespread, rampant use of antibiotics before blood sampling 
and inherent variations of the blood culture to give positive result in 
relation to duration of fever. And also it is less sensitive than bone 
marrow culture which is a painful cumbersome procedure. To overcome 
this problem an alternative gold standard investigation should be 
established.  
With the recent sequencing of the entire serotype Typhi genome, it 
may be possible to identify other antigens , such as fimbrial antigens that 
may produce an antibody response specific to serotype Typhi. 
Possibilities of more sophisticated molecular techniques for diagnosis like 
PCR, should be explored. 
 
 
Proforma 
CURRENT PATTERN OF ENTERIC FEVER IN CHILDREN:A 
PROSPECTIVE CLINICAL AND MICROBIOLOGICAL STUDY 
Serial number:    Name: 
Age:                  Sex:               IP No: 
Address: 
 
Date of admission: 
Complaints: 
Fever: 
Duration: 
Pattern: 
Associated chills/rigor: 
Bowel habits:(constipation/diarrhoea): 
Vomiting: 
Abdominal pain: 
Abdominal distension: 
Cough: 
Anorexia: 
Joint pain: 
Myalgia: 
Epistaxis: 
Head ache: 
Alteration in mental status: 
Seizures: 
Loss of consciousness: 
H/o contact with known typhoid fever case: 
Prior treatment history: 
Immunisation for typhoid fever 
Vital signs: 
 
 
         Pulse Rate: 
         Blood Pressure: 
         Respiratory Rate: 
         Temperature: 
General examination: 
Anemia: 
Icterus: 
Edema: 
Lymphadenopathy: 
Toxic look: 
Rose spot: 
Coated tongue: 
Others: 
Systemic examination: 
Abdomen: 
 
Respiratory system: 
 
Cardio vascular system: 
 
Central nervous system: 
 
Musculo skeletal: 
Investigations: 
CBC      Urine R/E: 
                                                                        Culture & Sensitivity: 
 
Peripheral Smear-MP:   Chest  X Ray: 
 
 
 
LFT:      Mantoux Test: 
 
Widal Test:                       Titre:    O             H 
Typhidot Assay: 
Blood culture: 
Organism:       
  A\Ntibiotic Susceptibility Pattern 
Ampicillin Ciprofloxacin Cotrimoxazole 
   
 
Cefotaxim Norfloxacin Amikacin 
   
 
Treatment: 
 
Follow up: 
Features  D1 D2 D3 D4 D5 D6 D7 
Fever        
Organomegaly        
Complications        
Hospital stay         
 
Alternate diagnosis if reached: 
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